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Abstract
Background: The duration of untreated psychosis (DUP) is negatively associated with
objective recovery among people with first-episode psychosis (FEP). However, the
association between DUP and subjective recovery is not known. Objectives: To investigate
whether DUP is statistically associated with self-perceived recovery scores (subjective
recovery) and occupational activity (objective recovery) 10-years after the first episode of
psychosis. Methods: A cohort of 65 clients from an early intervention program completed a
battery of outcome measures 10-years following initial treatment for FEP (March 1997 to
February 2002). Multiple linear or logistic regression analyses were used to estimate the
association between DUP and both measures of recovery, adjusting for potential confounding
factors. Results: We did not find a statistically significant association between between DUP
and either weeks of occupational activity (OR = 1.26, 95%CI: 0.81 to 1.95) or self-perceived
recovery score (ß = -0.73, 95%CI: -2.42 to 0.97), adjusting for 10-year confounding factors.
However, we found a negative association between negative symptoms at 10-year follow-up
and occupational activity (OR = 0.69, 95%CI: 0.57 to 0.84), as well a positive association
between perceived social support score at 10-year follow-up and self-perceived recovery
score (ß = 0.94, 95%CI: 0.45 to 1.42), adjusting for 10-year confounding factors.
Conclusions: Our findings suggest that factors other than DUP have an impact on objective
and subjective recovery at 10-year follow-up. Further research examining factors associated
with self-perceived recovery after a first episode of psychosis is warranted.
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Chapter 1!!

1!

Background & Introduction

In this chapter, the overall purpose of this thesis is provided in Section 1.1, followed by
background information about psychosis, first-episode psychosis, and early intervention
programs in Sections 1.2, 1.3, and 1.4, respectively. Thereafter in Section 1.5, the
rationale for this thesis is provided, followed by a brief description of our thesis
objectives in Section 1.6. Next in Section 1.7, the data source is described. Subsequently
in Section 1.8, the contributions to this thesis are outlined. Lastly, an overview of the
chapters in this manuscript is provided in Section 1.9.

1.1! Overall Purpose
The overall purpose of this thesis is to investigate whether the length of time psychosis is
left untreated is associated with a person’s judgement of his or her recovery from firstepisode psychosis at 10-year follow-up.

1.2! Background Information: Psychosis
1.2.1!

Psychosis Overview

Psychosis is a syndrome or a set of symptoms; it is not a mental health diagnosis or
disease (Keks & Blashki, 2006). A range of symptoms characterize psychosis, and these
symptoms are typically categorized as either “positive” (present or added on) or
“negative” (absent or reduced), and are often referred to as “psychotic symptoms” or
“symptoms of psychosis” (Jones, Hacker, Cormac, Meaden, & Irving, 2012; Minas et al.,
1992). Examples of positive symptoms include delusions, which are false, unjustified
beliefs and judgments, and hallucinations which involves seeing, hearing, tasting, or
smelling something that is not actually present (American Psychiatric Association, 2013).
Examples of negative symptoms include reduction in speech and difficulty in thinking
(American Psychiatric Association, 2013). In general, these symptoms change a person’s
state of mind in which he or she is unable to differentiate what is real (American
Psychiatric Association, 2013), and the person is often described as being “out of touch
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with reality” or having a “distorted perception of reality.” The number, type, and severity
of psychotic symptoms can vary from person to person depending on the underlying
cause of psychosis.
There are a number of potential causes of psychosis. These include, but are not limited to
alcohol and drug (e.g., cocaine) use or withdrawal, brain injury, other health conditions
(e.g., epilepsy), intense stress, or an underlying mental illness (American Psychiatric
Association, 2013). In this thesis, psychosis as a consequence of a mental illness will be
considered, which may occur in the context of several different psychiatric disorders,
including schizophrenia, delusional disorder, bipolar disorder, or depression with
psychotic features. These are typically classified as either non-affective (e.g.,
schizophrenia) versus affective (e.g., bipolar disorder) (e.g., ElTayeban, ElGamal,
Roshdy, & Al-Khadary, 2014; Salvatore et al., 2007) or as schizophrenia-spectrum versus
other psychotic disorder (American Psychiatric Association, 2013).
It has been estimated that approximately 3% of the general population will experience
psychosis at some point over the course of their lifetime (Perala et al., 2007). Typically,
people experience their first episode of psychosis in their late teens and early twenties
(Kessler et al., 2007). During this period of late adolescence and early adulthood,
personal and professional development and growth occurs (Harris et al., 2005; Mackrell
& Lavender, 2004), which can potentially be disrupted by the onset of psychosis,
consequently having a negative impact on the person and his or her family (Reed, 2008).
Fortunately, psychosis can be treated, with earlier treatment resulting in better outcomes
(Marshall et al., 2005; Perkins, Gu, Boteva, & Lieberman, 2005). In addition, some
people will never experience psychosis (i.e., psychotic episode) again and do recover,
whereas other suffer a relapse and may or may not recover (Robinson et al., 1999).

1.2.2!

Phases of Psychosis

An episode of psychosis typically occurs in three phases, beginning with the prodrome
(or prodromal) phase, followed by the acute phase, and ending with the recovery phase
(Figure 1.1). The duration of each phase varies from person to person. During the

3

prodrome, the person experiences gradual non-specific changes in thoughts, feelings, and
behaviours such as sleep disturbance, depressed mood, irritability, reduced concentration,
drive, and motivation (Yung & McGorry, 1996). During the acute phase, a person
experiences hallucinations, delusions, or other symptoms of psychosis for which
treatment should be sought immediately to prevent any further interference in the
different domains of a person’s life. During the final phase, the recovery phase,
symptoms of psychosis alleviate or disappear completely, allowing the person to better
cope with daily life and resume roles or activities that he or she was engaged in prior to
the psychotic episode (Davidson, O’Connell, Tondara, Lawless, & Evans, 2005).

Figure 1.1: Phases of Psychosis.
Importantly, the last phase highlights that recovery after a psychotic episode is possible;
however, it is highly variable (de Koning et al., 2009; Marshall & Rathbone, 2011).
While some may recover after a psychotic episode, others do not. Even among those that
do recover, some may suffer one or more relapses, and may or may not recover again.
It is also important to highlight that the elimination or reduction of psychotic symptoms
does not directly equate with a person being in the recovery phase. Although remission of
symptoms is seen as a sign of recovery for some, for others it is either not acknowledged
as a sign of recovery or it is one of many signs of recovery that have yet to be attained
such as regaining previous social functions, cognitive functions, or trust in others
(Eisenstadt, Monteiro, Diniz, & Chaves, 2012; Lam et al., 2010; Windell, Norman, &
Malla, 2012).
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1.3! Background Information: First-Episode Psychosis
1.3.1!

Definition

First-episode psychosis has garnered increased research and clinical interest over the past
two decades, although significant heterogeneity exists in how it is operationalized.
Typically, it is operationalized based on one of the following three definitional
categories: (i) the first treatment contact for a psychotic disorder; (ii) antipsychotic
medication use for a specified length of time; (iii) the duration of psychotic symptoms
(Breitborde, Srihari, & Woods, 2009).
Regardless of the definitional category that is used, first-episode psychosis, in general,
refers to a person who is in the early stage of a psychotic illness and who has received
minimal or no prior treatment (Breitborde, Srihari, & Woods, 2009).

1.3.2!

Incidence

A recent study conducted by Anderson and colleagues (2012) estimated the age and
gender standardized annual incidence of first-episode schizophrenia-spectrum psychosis
in Quebec among people aged 14 to 25 years to be 82.9 per 100 000 for males and 32.2
per 100 000 for females. A 3-year period (2004-2006) was used to identify people with
first-episode schizophrenia (Anderson, Fuhrer, Abrahamowicz, & Malla, 2012).
Approximately 65% of people with first-episode psychosis present with schizophreniaspectrum, which includes diagnoses such as schizophrenia, schizophreniform disorder,
schizoaffective disorder, or delusional disorder (Kirkbridge et al., 2006; Proctor, Mitford,
& Praxton, 2004; Reay, Mitford, McCabe, Paxton, & Turkington, 2010).

1.4! Background Information: Early Intervention Programs
Over the past 20 years, an increasing number of specialized early intervention programs
have been developed and implemented in countries around the world, including Canada
(Edwards & McGorry, 2002; McGorry, Killackey, & Yung, 2008), which has at least one
such program in each of the 10 provinces, with more than 60 programs across the
province of Ontario. The proliferation of these programs may in part be attributed to the
growing interest in improving outcomes through early detection of positive symptoms

5

and the use of pharmacological, psychosocial, and/or vocational interventions targeting
the first two to five years after the onset of a first episode of psychosis, a critical period
(Birchwood, Todd, & Jackson, 1998; McGorry et al., 2007).
During the initial critical period, trajectories of outcomes are generally defined (Harrison
et al., 2001) and rates of relapse are relatively high (i.e., approximately 80%) (Bergé et al.
2015; Robinson et al., 1999). It is therefore not surprising that two of the primary
objectives of these programs are to alter the negative trajectory of outcomes by reducing
the duration of untreated psychosis through early detection and prompt initiation of
treatment (Singh & Fisher, 2005), and by preventing relapse (Alvarez-Jimenez et al.,
2012; Robinson et al., 1999; Schooler et al., 2005).

1.4.1!

Shorten the Duration of Untreated Psychosis

A long duration of untreated psychosis is associated with a range of poor outcomes
(Norman & Malla, 2001; Norman et al., 2005; Marshall et al., 2005; Perkins et al., 2005);
however, it is one of the few modifiable prognostic factors of poor outcome (Chang et al.,
2012b; Singh & Fisher, 2005). Therefore, the primary aim of specialized early
intervention programs is to improve outcomes in people with a first episode of psychosis
by shortening the duration of untreated psychosis through early detection and treatment
(Chang et al., 2012b; Singh & Fisher, 2005).
There does appear to be some uncertainty as to whether the effects of shortening the
duration of untreated psychosis are sustained over the long-term, which may in part be
attributed to the limited number of prospective outcome studies with follow-up periods of
10-years or more. There also appears to be some emerging interest in the association
between the duration of untreated illness and poor outcome, which is the length of time
between the onset of any earlier non-psychotic signs of illness and initiation of treatment
(Crumlish et al., 2009), which has been found to be more consistently associated with
poor outcome than the duration of untreated psychosis (e.g., Crumlish et al., 2009;
Dell’Osso, Glick, Baldwin, & Altamura, 2012; Harris et al., 2005; Keshavan et al., 2003;
Norman et al., 2012). As a result, many specialized early intervention programs are also
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now targeting people believed to be in the prodromal phase of psychosis, or at an ultrahigh risk for developing a psychotic disorder (de Koning et al., 2009).

1.4.2!

Relapse Prevention

Vulnerability to relapse is high during the first 5-years following initial onset (Bergé et
al., 2015), with most people experiencing a relapse at least once during the two to fiveyear period (Gitlin et al., 2001; Robinson et al., 1999). Moreover, the cumulative
incidence is 80% at 5-year follow-up (Robinson et al., 1999).
Prevention of relapse is important because experiencing a relapse can potentially result in
disengagement from meaningful activities (e.g., school or work) and from family or
friends, which can adversely impact a person’s psychosocial and vocational development
(Penn, Waldheter, Perkins, Mueser, & Lieberman, 2005), and may impede recovery.
Clinically, prevention of relapse is important because a future response to treatment such
as antipsychotic medication may potentially be reduced after each relapse (Tibbo, Malla,
Manchanda, Williams, & Joober, 2014), and progressive gray matter loss may occur
based on the durations of relapses (Andreasen, Liu, Ziebell, Vora, & Ho, 2013).
Targeting modifiable risk factors (e.g., duration of untreated psychosis) has been
suggested to contribute to the relatively lower relapse rates observed among people
treated and followed-up in an early intervention program for psychosis, compared to
those in routine care (Malla, Norman, Bechard-Evanc, Schmitz, Manchanda, & Cassidy,
2008). Despite the lower rates (i.e., 20% to 30% during 2-years), risk of relapse continues
be a barrier to recovery (Malla et al., 2008; Tibbo, Malla, Manchanda, Williams, &
Joober, 2014). Moreover, identification of factors associated with relapse has been
suggested to facilitate the development of effective prevention strategies (Hui et al.,
2013).

1.5! Study Rationale
With emerging clinical and research interest in the assessment of recovery as an outcome
among people with first-episode psychosis, identification of factors that may impede
recovery is important to promote, as well as sustain recovery. Given that the duration of
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untreated psychosis has been identified as one of the few modifiable risk factors of poor
outcome in people with first-episode psychosis, its relationship to recovery is of interest.
However, the existing literature on the relationship between duration of untreated
psychosis and recovery has focused on one dimension of recovery, objective recovery,
and this relationship has been assessed over a short period of time (< 10-years). To
addresses the current gaps in the literature, we investigated whether the duration of
untreated psychosis is associated with the other dimension of recovery, subjective
recovery, and we assessed this relationship over a 10-year follow-up period.

1.6! Thesis Objectives
Using data from 65 clients of an early intervention program who received initial
treatment for a first episode of psychosis at least 10-years ago, the four objectives of this
thesis were:
1.! To examine the association between objective and subjective measures of
recovery at 10-year follow-up.
2.! To investigate whether the duration of untreated psychosis is associated with
objective recovery, adjusting for potential confounding variables.
3.! To examine whether the duration of untreated psychosis is associated with
subjective recovery, adjusting for potential confounding variables.
4.! To investigate whether relapse mediates the relationship between the duration of
untreated psychosis and subjective recovery, adjusting for potential confounding
variables.
A detailed description of each of these four objectives and hypotheses will be provided in
Chapter 2, with reference to our conceptual framework.

1.7! Data Source: PEPP Data Set
The data used in this thesis came from a prospective cohort study (i.e., source study)
titled, “Assessment of 10 Year Outcomes for Clients of the Prevention and Early
Intervention Program for Psychoses (PEPP).” The purpose of this study was to assess
outcomes of clients 10-years following initial treatment for a first episode of psychosis at
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PEPP (London, Canada). Primary outcomes assessed were levels of positive and negative
symptoms, level of functioning, and self-perceived recovery. Secondary outcomes
assessed were dysfunctional attitudes, neurocognition, self-stigma, and self-efficacy.
The five main objectives of this study included:
1.! Compare 10-year outcomes with those at 5-year follow-up.
2.! Identify early predictors of 10-year outcomes.
3.! Examine outcomes not previously assessed in earlier follow-up assessments with
the same cohort of clients.
4.! Assess the degree of correspondence between symptomatic, functional, and
subjective measures of outcome.
5.! Examine in greater detail the nature of negative symptoms at 10-years, and
examine the correlates/predictors of variation in these symptoms.
Objectives 1 to 3 of this thesis aligned with two of the five main objectives of the source
study, specifically objectives 2 and 4.

1.8! Contributions to Current Study
My contribution to the current study began with selecting our exposure and outcome
variables of interest in collaboration with Dr. Kelly Anderson, my thesis supervisor, and
Dr. Ross Norman, the primary investigator of the source study. I then formulated the
thesis objectives and corresponding hypotheses in collaboration with Drs. Anderson and
Norman. Thereafter, I proposed a statistical analysis plan for each of the objectives with
consultation from Dr. Anderson. The statistical analysis plan included adjustment of
potential confounding variables in our preplanned statistical analyses, which were
identified as such from a conceptual framework that Dr. Anderson and I created, based on
available data. The objectives and statistical analysis plan were reviewed by Dr. Norman
to ensure that we did not miss anything from a clinical perspective. Dr. Neil Klar, a
member of my thesis supervisory committee, also reviewed the objectives and statistical
analysis plan to check for feasibility and to ensure that we did not miss anything from a
statistical perspective. Upon approval from Drs. Norman and Klar, I submitted a request
for access to a subset of the variables. After I received the data set from Dr. Norman, I
‘cleaned’ the data (Chapter 3), examined the amount of missing data using several
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approaches (Chapter 3), selected a method to handle missing data (i.e., multiple
imputation) with consultation from Drs. Anderson and Klar, and then assessed for multicollinearity. Thereafter, I conducted all analyses and interpreted findings with
consultation from Dr. Anderson. Lastly, my contribution ended with the writing of this
manuscript. The critical revision of this manuscript for content, structure, writing clarity
and quality was an on-going process that involved Drs. Anderson and Klar.

1.9! Overview of Thesis Chapters
The current study will be described in greater detail in the next four chapters:
Chapter 2 provides a detailed description of the duration of untreated psychosis, our
exposure variable of interest, and recovery (i.e., objective and subjective recovery), our
outcome variable of interest. It also summarizes the existing literature assessing the
association between these variables in people who were initially treated at an early
intervention program for either a first episode of psychosis or a first episode of
schizophrenia.
Chapter 3 describes the study procedures of the source study, along with the variables
and measures included in the data set. It then provides an overview of the multiple
imputation method used to handle missing data, and it outlines our statistical analysis
plan comprised of a point biserial correlation, a multiple logistic regression analysis, a
multiple linear regression analysis, and a mediation analysis for objectives 1, 2, 3, and 4,
respectively.
Chapter 4 presents findings from the main analyses that included data from a cohort of
65 clients of PEPP, which were analyzed using Stata (version 14). It then presents
findings from the two sets of sensitivity analyses that involved the use of complete data,
as well as the use of imputed data with the duration of untreated illness as the exposure
variable in place of the duration of untreated psychosis.
Chapter 5 discusses key findings, including the following statistically significant
findings: (i) duration of untreated psychosis is not associated with both measures of
recovery, whereas the duration of untreated psychosis is associated with both measures of
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recovery; (ii) perceived social support is positively associated with subjective recovery;
(ii) negative symptoms are negatively associated with objective recovery. It then
highlights that in a clinical context, a more comprehensive overview of a person’s
recovery after a first episode of psychosis is attained by assessing different dimensions of
recovery, and factors other than the duration of untreated psychosis need to be targeted to
enhance a person’s subjective and objective recovery from a first episode of psychosis.
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Chapter 2!!

2!

Literature Review

In this chapter, a detailed description of the duration of untreated psychosis and recovery
is provided in Sections 2.1 and 2.2, respectively. In Section 2.3, the existing literature on
the association between the duration of untreated psychosis and recovery is summarized.
In Section 2.4, gaps in the existing literature are discussed. Thereafter, in Section 2.5, our
conceptual framework is presented. Lastly, a detailed description of the thesis objectives
and hypotheses with reference to the conceptual framework is provided in Section 2.6.

2.1! Duration of Untreated Psychosis
2.1.1!

Definition, Components, & Measurement

Definition
The duration of untreated psychosis (DUP) or treatment delay is generally defined as the
time interval (t1 < DUP < t2) between the onset of psychotic symptoms (e.g., positive
symptoms such as hallucinations and delusions; t1) and the initiation of adequate
treatment (e.g., antipsychotic medication for a period of 1 month; t2) (Compton et al.,
2007; Ienciu, Romoşan, Bredicean, & Romoşan, 2010; Malla, Norman, Scholten, &
Manchanda, 2005; McGlashan, 1999; Tang et al., 2014). Essentially, the duration of
untreated psychosis measures ‘delay in treatment’ for psychosis (Malla, Norman,
Scholten, & Manchanda, 2005). Thus, the terms ‘duration of untreated psychosis’ and
‘treatment delay’ are often used interchangeably. A list of other synonyms is provided in
Appendix A.
Components
The duration of untreated psychosis can be conceptualized as being comprised of three
temporally separate components: 1) A help-seeking component (i.e., Help-Seeking
Delay), defined as the time interval between the onset of psychotic symptoms and first
contact with health services (e.g., general practitioner); 2) A referral component (i.e.,
Referral Delay), defined as the time interval between first contact with health services
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and referral to mental health care services; and 3) A mental health care services
component (i.e., Delay in Mental Health Care Service), defined as the time interval
between referral to mental health care services and initiation of adequate treatment
(Figure 2.1) (Boonstra, Sterk, Wunderink, Sytema, De Haan, & Wiersma, 2012; Brunet,
K., Birchwood, M., Lester, H., & Thornhill, 2007). A recent review of the multifaceted
determinants of the duration of untreated psychosis suggests that patient-, illness-, and
family level factors are more likely to influence the help-seeking component of the
duration of untreated psychosis, whereas system-level factors are more likely to influence
the referral component of the duration of untreated psychosis (Compton & Broussard,
2011). Some of these factors are modifiable, whereas others are not. Factors that
influence and/or are more likely to influence the mental health care services component
of the duration of untreated psychosis have not readily been investigated. However,
Boonstra and colleagues (2012) reported that delay in mental health care service was
significantly longer for people with first-episode psychosis who not only already received
treatment for other diagnoses from a mental health care service, but also for those living
in rural areas compared to those living in urban areas.

Figure 2.1: Components of DUP. Note: This figure is modified from French, Smith,
Shiers, Reed, & Rayne (2010). DUP = Duration of Untreated Psychosis; t1 = time-point
one, which corresponds to the onset of DUP; t2 = time-point two, which corresponds to
the endpoint of DUP.
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Measurement
Measurement of the duration of untreated psychosis (t1 < DUP < t2) involves estimating
the length of time (e.g., weeks) that has elapsed between the onset of the duration of
untreated psychosis (t1) and the endpoint of the duration of untreated psychosis (t2)
(Compton, 2007; Norman & Malla, 2001) (Figure 2.1). The duration of untreated
psychosis estimates obtained will vary depending on how the onset (t1) and the endpoint
(t2) are operationalized (Compton, 2007; Norman & Malla, 2001). Variation in the
operationalization of the onset and endpoint of the duration of untreated psychosis is
apparent in studies included in Table 2.1. For instance, operationalization of the onset of
the duration of untreated psychosis included the onset of first positive psychotic
symptoms or psychosis onset (Evensen et al., 2012; Friis et al., 2015). Operationalization
of the endpoint of the duration of untreated psychosis included initiation of antipsychotic
medication or hospitalization (Compton, 2007; Friis et al., 2015; Jaracz et al., 2015).
Variation in the operationalization of the onset and endpoint of the duration of untreated
psychosis makes comparison across studies difficult.
Definition of DUP in this Thesis
We defined the duration of untreated psychosis as the length of time in weeks between
the date of onset of positive psychotic symptoms (e.g., hallucination) to the date of
initiation of adequate treatment. Adequate treatment referred to treatment with
antipsychotic medication for 1-month (or until symptoms have resolved) or psychosocial
treatment (i.e., assertive case management) for 1-month. These dates were extracted from
select items from the Course of Onset or Relapse Schedule (CORS; Norman & Malla,
2002).

2.1.2!

Influence of DUP on Outcomes

There have been two systematic reviews of the literature specifically investigating the
link between the duration of untreated psychosis and outcome in people with either firstepisode psychosis or first-episode schizophrenia (Marshall et al., 2005; Perkins, Gu,
Boteva, & Lieberman, 2005). With the exception of one study, both reviews consisted of

14

studies with follow-up periods of two-years or less. The conclusions of each review were
consistent: A longer duration of untreated psychosis is associated with poorer short-term
outcomes (Marshall et al., 2005; Perkins, Gu, Boteva, & Lieberman, 2005). It remains
unclear whether the duration of untreated psychosis is associated with long-term (> 10years) outcomes, attributed in part to the limited number of empirical studies with followup periods of 10-years or more.
We conducted a literature search of studies examining the association between the
duration of untreated psychosis and long-term (> 10-years) outcomes in people with firstepisode psychosis or first-episode schizophrenia. Table 2.1 summarizes study
characteristics and main findings of studies identified by our literature search.
All studies (n = 12) were conducted in countries other than Canada and were published
between 2005 and 2016. Of all the studies, half of the studies (n = 6) had a length of
follow-up of 10-years (Austin et al., 2015; Evensen et al., 2012; Friis et al., 2016; Rund et
al., 2015; Shrivastava et al., 2010; White et al., 2009), while a majority of the remaining
studies (n = 4) had a length of follow-up of more than 10-years (Hill et al., 2012; Ichinose
et al., 2010; Röpcke & Eggers, 2005; Tang et al., 2014), and the remaining few studies
(n = 2) had lengths of follow-up of both 10 and more than 10-years (Jaracz et al., 2015;
Kinoshita et al., 2005). The rate of follow-up ranged from 29% (Ichinose et al., 2010) to
87% (Rund et al., 2015), and the sample size ranged from 31 (Ichinose et al., 2010) to
304 (Austin et al., 2015). The mean duration of untreated psychosis ranged from 6 to 88
weeks (Evensen et al., 2012; Hill et al., 2012).
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Table 2.1: Summary of Studies (n = 12) Examining the Relationship between DUP and Long-Term (> 10-years) Outcomes in People with
First-Episode Psychosis or First-Episode Schizophrenia.
Study
Authors
(Year)

Country

Sample Source

Length of
Follow-up

Sample
Size at
Follow-up

Rate of
Follow-up
n/total (%)

Kinoshita
et al.
(2005)

Japan

10 & 15
years

52 Patients
with FirstEpisode
Schizophrenia

52/97
(54%)

Röpcke &
Eggers
(2005)

Germany

Psychiatric Care
Organizations
(Private mental
hospitals, Prefectural
mental hospital, Private
Psychiatry Clinics,
Public General
Hospitals, and Health
Centers)
Outpatient Clinic for
Child & Adolescent
Psychiatry

15.4
years+

39 Patients
with a
diagnosis of
Early Onset
Schizophrenia

White
et al.
(2009)

United
Kingdom

National Health Service
Psychiatric Units

10 years

69 Patients
with FirstEpisode
Psychosis

Measurement of DUP
Onset
Onset of
illness

Endpoint
Initial visit at a
medical
facility

39/55
(71%)

Onset of first
psychotic
symptoms

First
antipsychotic
treatment

69/109
(63%)

Onset of first
positive
psychotic
symptoms

Index
admission

DUP
Categorization

Mean
DUP

Outcome(s)/
Outcome Measures

Relationship between
DUP & Outcome(s)
[Yes/No]

9.9
months

Good Outcome =
Complete remission
with or without
relapse
Poor Outcome =
Incomplete remission
with or without
relapse or continuous
psychotic illness
Psychopathological
and Social Outcome
Clinical Global
Impression (CGI),
Psychosocial
functioning (Global
Assessment of Social
Function, Negative
Symptoms, Positive
Symptoms, and
General Psychopathology (PANSS))
Functional Outcome,
Service Contact/
Dependency, &
Outcome Symptom
Burden

A long DUP was
significantly associated
with poor outcome at
10-year follow-up, but
not at 15-year followup.

Not
provided

24.68
weeks

DUP was not
significantly associated
with any of the
outcomes at follow-up.

DUP was independently associated with
poor outcome
symptom burden at 10year follow-up.
[Yes]

Note: DUP = Duration of Untreated Psychosis; + = Mean length of follow-up (10.2-21.2 years); n = count; PANSS = Positive and Negative Syndrome Scale; CGI = Clinical Global Impression; & =
and; % = Percentage.
(Continued)
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Table 2.1: Summary of Studies (n =12) Examining the Relationship between DUP and Long-Term (> 10-years) Outcome in People with
First-Episode Psychosis or First-Episode Schizophrenia.
Study
Authors
(Year)
Ichinose
et al.
(2010)*!

Shrivastava
et al.
(2010) *

Country

Sample Source

Length of
Follow-up

Japan!

Medical Institutions with
Psychiatry Departments
(Private psychiatry
hospitals & clinics,
Prefectural psychiatry
hospital, Public General
Hospital Psychiatry
Departments, and Health
Centers)!
Non-Governmental
Psychiatric Hospital

28 years!

India

10 years

Sample
Size at
Follow-up

Rate of
Follow-up
n/total (%)

31 Patients
with FirstEpisode
Schizophrenia !

31/107
(29%)!

101
Hospitalized
Patients with
First-Episode
Schizophrenia

101/200
(51%)

Measurement of DUP

Onset
Disease Onset
!

Positive
symptoms
(hallucinations,
delusions, odd
beliefs, and
thought disorder),
negative
symptoms
(depression,
dysphoria, apathy,
anergia, apathy,
and amotivation),
and social decline
(withdrawn
behavior, poor
interpersonal
relationship,
social avoidance,
and lack of
interest in
education or
work)

Endpoint
Start of
treatment at
a medical
institution !

Not
Described

DUP
Categorization

Mean
DUP

Outcome(s)/
Outcome Measures

Relationship between
DUP & Outcome(s)
[Yes/No]

Short DUP =
< 3 months

8.97
months!

Global Assessment
Schedule (GAS),
Disability Assessment
Schedule (DAS), and
Clinical Global
Impression (CGI)
!

A long DUP was
significantly associated
with decreased GAS,
DAS, and CGI.
[Yes]!

12.7
months

Clinical: Clinical
Global Impression,
Psychopathology,
Depressive
Symptoms, Factors of
Compliance,
Extrapyramidal
Symptoms,
Aggression,
Hospitalization, &
Suicidality

DUP was not
significantly associated
with any of the clinical
or social outcomes.
[No]

Long DUP =
> 4 months!

Short DUP =
< 12 months
Long DUP =
> 12 months

Social: Quality of
Life, Global
Functioning,
Independent Living,
Family Burden, &
Social Burden

Note: *DUP main focus; DUP; Duration of Untreated Psychosis; n = count; GAS = Global Assessment Schedule; DAS = Disability Assessment Schedule; CGI = Clinical Global
Impression; & = and; % = Percentage.

(Continued)
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Table 2.1: Summary of Studies (n =12) Examining the Relationship between DUP and Long-Term (> 10-years) Outcome in People with
First-Episode Psychosis or First-Episode Schizophrenia.
Study
Authors
(Year)

Country

Sample Source

Length of
Follow-up

Sample
Size at
Follow-up

Rate of
Follow-up
n/total (%)

Evensen
et al.
(2012)

Norway
&
Denmark!

The Treatment &
Intervention in Psychosis
Study (TIPS); Specialist
Psychiatric Health-Care
Services of four
Scandinavian Health Care
Sectors !

10 years!

178 FirstEpisode
Psychosis
Patients
(Inpatients &
Outpatients)!

178/301
(59%)!

Cluain Mhuire Family
Centre (provides
psychiatric service) or the
St John of God Hospital

12 years

123 FirstEpisode
Psychosis
Patients

123/171
(72%)

!

Hill et al.
(2012)*

Tang
et al.
(2014)*

Ireland

Hong
Kong

Public Hospitals

13 years

96 FirstEpisode
Psychosis
Patients

Measurement of DUP

Onset
First positive
psychotic
symptoms
!

96/153
(63%)

Onset of the
first psychotic
symptom

Onset of
positive
psychotic
symptoms

Endpoint
Start of the first
adequate
treatment of
psychosis

!
Start of
antipsychotic
treatment

Treatment
initiation

DUP
Categorization

Mean
DUP

Outcome(s)/
Outcome Measures

Relationship between
DUP & Outcome(s)
[Yes/No]

!

6 weeks!

Apathy !

DUP was not
significantly associated
with self-rated apathy at
10-years follow-up.
[No]!

< 1 month;
>1 and <3
months;
>3 months and
<1 year;
>1 year

20.3
months

Symptomatic: Positive
Symptoms, Negative
Symptoms,
Disorganized
Symptoms, Symptom
Severity, & Remission

Longer DUP was
significantly associated
with poorer remission
status, more severe
positive and negative
symptoms, and greater
impairment in general
functioning, social
functioning, as well as
quality of life.
[Yes]

Short DUP =
< 30 days
Medium DUP
= 31-180 days
Long DUP =
> 180 days

180
days

Functional:
General/Global
Functioning, Quality
of Life, Level of
Functioning, Social
Functioning, &
Occupational
Functioning
Clinical –
Symptomatic
Remission

DUP longer than 30
days adversely impacts
the long-term outcome.
[Yes]

Note: *DUP main focus; DUP = Duration of Untreated Psychosis; n = count; & = and; % = Percentage.
(Continued)
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Table 2.1: Summary of Studies (n =12) Examining the Relationship between DUP and Long-Term (> 10-years) Outcome in People with
First-Episode Psychosis or First-Episode Schizophrenia.
Study
Authors
(Year)

Country

Sample Source

Length of
Follow-up

Sample
Size at
Follow-up

Rate of
Follow-up
n/total (%)

Denmark!

OPUS trial; Inpatient
& Outpatient Mental
Health Services!

10 years!

304 People with
First-Episode
Psychosis !

304/496
(61%)!

Hospital

9 years+

64 Patients
Hospitalized for
First-Episode
Schizophrenia

The Treatment
&Intervention in
Psychosis Study
(TIPS); Specialist
Psychiatric HealthCare Services of four
Scandinavian Health
Care Sectors
The Treatment
&Intervention in
Psychosis Study
(TIPS); Specialist
Psychiatric HealthCare Services of four
Scandinavian Health
Care Sectors

10 years

10 years

Measurement of DUP
Onset

Austin
et al.
(2015)
!

Jaracz et
al. (2015)

Poland

Rund et
al.
(2015)*

Norway &
Denmark

Friis et al.
(2016)

Norway &
Denmark

DUP
Categorization

Mean
DUP

Outcome(s)/
Outcome Measures

Relationship between
DUP & Outcome(s)
[Yes/No]

!

52 weeks
(full;
baseline
sample)!

Positive and Negative
Symptom Trajectories !

Good Outcome =
simultaneously
meeting criteria for
symptomatic and
functional remissions,
as well as satisfying
quality of life
Poor Outcome =
Not meeting all of the
criteria of a good
outcome
Neurocognition

Longer DUP was
associated with poorer
positive symptom
trajectories (i.e.,
higher levels of
psychotic symptoms).
[Yes]
Longer DUP was
significantly
associated with poor
outcome.
[Yes]

Endpoint

At least one
psychotic
symptom
definitely
present
!

Initiation of
treatment!

64/86
(74%)

Appearance of
the first
psychotic
symptoms

First psychiatric
hospitalization

10.4
months
(baseline
sample)

261 FirstEpisode
Psychosis
Patients
(Inpatients &
outpatients)

261/301
(87%)

PANSS score
of 4 or more
on one of the
following
items: P1, P3,
P5, P6, or G9

Antipsychotic
medication or
admission to the
hospital for
treatment of acute
psychosis

11 weeks

186 Patients
with NonAffective FirstEpisode
Psychosis
(Inpatients &
outpatients)

186/301
(62%)

Psychosis
onset = First
appearance of
being actively
psychotic

Start of the first
adequate treatment
of psychosis
(antipsychotic
medication or
hospitalization)

< 26 weeks
> 26 weeks

47.4 weeks

Time in Psychosis;
defined as time with
scores >4 on any of
the following PANSS
items: P1, P3, P5, P6,
and G9

Absence of a
significant association
between DUP and the
neurocognitive
composite score.
[No]
DUP of > 26 weeks
was significantly
associated with longer
time in psychosis
during the 10-year
follow-up period
[ Yes]

Note: *DUP main focus; DUP = Duration of Untreated Psychosis; n = count; + = Mean length of follow-up (7-11 years); PANSS = Positive and Negative Syndrome
Scale; P = Positive Scale; G = General Scale; & = and; % = Percentage.
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In the majority of the studies (n = 7), the duration of untreated psychosis was treated as a
continuous variable, based on the assumption that the duration of untreated psychosis has
a linear effect on outcomes (Tang et al., 2014), such that the likelihood of poor outcomes
increases as the duration of untreated psychosis increases. In the remaining studies (n =
5), the duration of untreated psychosis variable was categorized or dichotomized, based
on the assumption that the duration of untreated psychosis has a threshold effect on
outcomes (Singh, 2007; Tang et al., 2014), such that the duration of untreated psychosis
will have no effect on outcomes unless a particular threshold value is reached or exceed.
Once the threshold value of the duration of untreated psychosis is reached or exceeded,
the likelihood of a poor outcome increases. Different cut-off values were used to classify
the duration of untreated psychosis as “long.” For instance, Tang and colleagues (2014)
defined “long” as greater than four-months, whereas Ichinose and colleagues (2010)
defined “long” as greater than one-year.
Overall, a majority of studies (n = 8) reported a statistically significant relationship
between the duration of untreated psychosis and long-term outcomes (Austin et al., 2015;
Friis et al., 2016; Hill et al., 2012; Jaracz et al., 2015; Ichinose et al., 2010; Kinoshita et
al., 2005; Tang et al., 2014; White et al., 2009). Among the studies that kept the duration
of untreated psychosis as a continuous variable (n = 7), a few of these studies (n = 4)
reported that the longer the duration of untreated psychosis the poorer the outcome
(Austin et al., 2015; Jaracz et al., 2015; Kinoshita et al., 2005; White et al., 2009). These
outcomes included:
•! Poorer positive symptom trajectories (Austin et al., 2015)
•! Poor outcome (i.e., not meeting criteria for symptomatic and functional
remissions, nor satisfying quality of life) (Jaracz et al., 2015)
•! Higher outcome symptom burden (White et al., 2009)
Kinoshita and colleagues (2005) reported that a long duration of untreated psychosis
was significantly associated with poor outcome at 10-year follow-up, but not at 15year follow-up.
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Among the studies that categorized or dichotomized the duration of untreated psychosis
(n = 5), a majority of these studies (n = 4) reported that a longer duration of untreated
psychosis was significantly associated with poorer outcomes (Friis et al., 2016; Hill et al.,
2012; Ichinose et al., 2010; Tang et al., 2014). These poorer outcomes included:
•! Longer time in psychosis (Friis et al., 2016)
•! Poorer remission status, greater severity of positive and negative symptoms,
greater impairment in general functioning, social functioning, and quality of life
(Hill et al., 2012)
•! Decreased scores on the Global Assessment Schedule, Disability Assessment
Schedule, and Clinical Global Impression (Ichinose et al., 2010)
•! Poor symptomatic remission (Tang et al., 2014)

2.1.3!

Long DUP-Poor Outcome Link: Underlying Mechanism

To date, the mechanism underlying the observed association between a long duration of
untreated psychosis and poor short-term (< 10-years) or long-term (> 10-years) outcome
in people with first-episode psychosis is not yet known (Chou et al., 2015; Marshall et al.,
2005; Perkins, Gu, Boteva, & Lieberman, 2005). The duration of untreated psychosis has
been proposed to have a direct and/or indirect impact on outcomes because of its
hypothesized neurotoxic and/or socially toxic effects (Norman, 2014; Wyatt, 1991)
(Figure 2.2).

Figure 2.2: A Visual Representation of the Hypothesized Neurotoxic and Socially
Toxic Effects that a Long Duration of Untreated Psychosis has on Outcomes in
People with First-Episode Psychosis.
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Wyatt (1991) proposed that untreated psychosis is somehow neurotoxic because it results
in potentially irreversible damage to the brain, with longer durations of untreated
psychosis resulting in greater damage to the brain. Hypothesized mechanisms to explain
this toxicity include dopaminergic (catecholaminergic) hyperactivity and prolonged
hypothalamic-pituitary-adrenal activation (Andersen, Voineskos, Mulsant, Gerorge, &
McKenzie, 2014). Evidence for the possible neurotoxic effects of untreated psychosis is
inconclusive (Anderson et al., 2015; McGlashan, 2006; Rund, 2014).
Recently, Norman (2014) proposed that a longer duration of untreated psychosis may
have socially toxic effects, which mediate its impact on outcomes. He argues that a third
variable, specifically a psychosocial factor such as social support, may mediate the
relationship between duration of untreated psychosis and outcomes. For instance, a long
duration of untreated psychosis could result in poor social support, poor social support in
turn, could have an adverse impact on outcomes (Figure 2.2). Therefore, a long duration
of untreated psychosis has an impact on outcomes indirectly through a third variable,
poor social support. However, evidence for possible socially toxic effects is needed, with
examination of the mediating role of different types of social support and other
psychosocial factors (Norman, 2014).

2.1.4!

Long Term Outcome (> 10-years): Relapse

Based on our literature search of studies examining the association between the duration
of untreated psychosis and long-term (> 10-years) outcomes in people with first-episode
psychosis or first-episode schizophrenia, no study to date has examined relapse as a longterm outcome (Table 2.1).
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2.2! Recovery
2.2.1!

Definition of Recovery

The most influential definition of recovery was put forth by Anthony (Wallcraft, 2012):
“Recovery is described as a deeply personal, unique process of changing one’s
attitudes, values, feelings, goals, skills, and/or roles. It is a way of living a
satisfying, hopeful, and contributing life even with limitations caused by illness.
Recovery involves the development of new meaning and purpose in one’s life as
one grows beyond the catastrophic effects of mental illness. Recovery from
mental illness involves much more than recovery from the illness itself…”
(Anthony, 1993).
While this definition has not been widely accepted in its entirety, elements of this
definition have been extracted by others in ongoing efforts to define recovery. Therefore,
no standardized definition or set of criteria for recovery exists, which may it part be
complicated by the multi-dimensional nature of this construct (Davidson, O’Connell,
Tondora, Staehuli, & Evans, 2005; Harvey & Bellack, 2009; Liberman & Kopelowicz,
2005; Silverstein & Bellack, 2008).

2.2.2!
2.2.2.1!

Recovery Following a First Episode of Psychosis
Variability in Recovery

People can and do recover after a first episode of psychosis; however, considerable
variability exists (de Koning et al., 2009; Lam et al., 2010; Marshall & Rathbone, 2011).
Rates of recovery following a first episode of psychosis range between 14% (Austin et
al., 2013) to 29.4% (Verma, Subramaniam, Abdin, Poon, & Chong, 2012) depending on
how recovery was operationalized and the length of follow-up. Moreover, factors
perceived to facilitate or hinder recovery and the signs of recovery may potentially
contribute to the variability observed across people who have or have not recovered after
a first episode of psychosis. Even among those who have recovered, variability exists in
their recovery style.
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Factors Perceived to Facilitate or Hinder Recovery
From the perspective of people who have experienced a first episode of psychosis, there
are a number of factors that either facilitate or hinder one’ chance of recovery. Factors
perceived to facilitate recovery include social support, medication, having to care for
someone, spirituality, lifestyle modification, meaningful activities, individual
characteristics such as personal effort and hope, and interpersonal relationships with the
professional team and members of a psychoeducation group (de Wet, Swartz, & Chiliza,
2015; Eisenstadt, Monteiro, Diniz, & Chaves, 2012; Windell & Norman, 2012). Factors
such as stigma, substance use, and adverse effects of medication are perceived to hinder
recovery (de Wet, Swartz, & Chiliza, 2015; Eisenstadt, Monteiro, Diniz, & Chaves, 2012;
Lam et al., 2010; Windell & Norman, 2012).
Signs of Recovery
The signs or meaning of recovery varies based on the person that is being asked, such as
a clinician, family member, or the person who experienced a first episode of psychosis
(Lam et al., 2010). Even among those who experienced a first episode of psychosis, the
signs of recovery vary. Table 2.2 summarizes the signs of recovery as indicated by people
who experienced a first episode of psychosis. As summarized in Table 2.2, there are a
number of signs of recovery, each reflecting different domains of a person’s life, which
suggests that recovery is multidimensional and that assessment of recovery should take
into account a person’s functioning in different domains of his or her life.
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Table 2.2: Signs of Recovery as Indicated by People who Experienced a First
Episode of Psychosis.
Study

Sample
6 people treated for a first
episode of psychosis at an
early intervention program

Lam et al.,
(2010)

•!
•!
•!
•!

Eisenstadt et al.,
(2012)

16 people treated for a first
episode of affective or nonaffective psychosis at an
early intervention program

•!
•!
•!
•!

Windell et al.,
(2012)

30 people who received
initial treatment for a first
episode of psychosis at an
early intervention service 3
to 5-years ago

•!
•!
•!
•!
•!
•!
•!

Signs of Recovery
(Overall Themes)
Regaining previous cognitive functions (e.g., being able to
concentrate)
Regaining previous social functions (e.g., engage with family and
friends)
Being normal
No medication
Improvement in psychotic symptoms (decrease or absence)
Changes in social relationships (e.g., return to social life)
Renewed autonomy & independence (e.g., feel safe again to go out
alone)
Restoration of self-reliance & trust in others (i.e., trust themselves
and others)
Alleviation of symptoms, especially positive symptoms
Subjective control over the extent and influence of symptoms, and
reduction of distress associated with the symptoms
Regaining a sense of control and a coherent sense of self (e.g.,
acceptance of illness)
Engagement in meaningful activities (resume or engage in new work
and/or school)
Participation in social relationships (e.g., peer or romantic
relationships)
Taking medication
Medication discontinuance

Note: Signs of recovery (overall themes) as reported by participants in qualitative
interviews.
We also noted that divergent views exist as to whether taking medication is a sign of
recovery (Lam et al., 2010; Windell, Norman, & Malla, 2012). We further noted that
elimination or reduction of symptoms (Eisenstadt, Monteiro, Diniz, & Chaves, 2012;
Windell, Norman, & Malla, 2012) was found to be a common sign of recovery, which is
generally the sign of recovery acknowledged by clinicians (Lam et al., 2010). However,
for some, elimination or reduction of symptoms was not acknowledged to be a sign of
recovery (Lam et al., 2010), which illustrates that the signs of recovery according to the
clinician do not always align with those of the client. Therefore, it is important to
incorporate the signs or meaning of recovery based on perspectives of both the clinician
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and the client allowing them to work towards a shared set of objectives to promote
recovery (Ng et al., 2008).
Recovery Style
During the recovery phase of a first episode of psychosis (Figure 1.1), one of two
recovery styles is adopted including integration or integrative versus sealing or seal over
(Thompson, McGorry, & Harrigan, 2003). Those with an integrative recovery style
incorporate their psychotic episode experience as part of their overall life experience and
have a more optimistic outlook as he or she was able to learn new information about
themselves (Thompson, McGorry, & Harrigan, 2003). In contrast, those with a sealing
over recovery style tend to dissociate their psychotic episode experience from their
overall life experience in an effort to protect themselves from the stigma associated with
psychosis and to preserve their mental well-being (Thompson, McGorry, & Harrigan,
2003). Furthermore, those with an integrative recovery style tend to be more compliant
with treatment, whereas those with the latter recovery style deny that anything is wrong
and resist treatment (McGlashan & Levy, 1997; Thompson, McGorry, & Harrigan,
2003), which may explain why those with the former recovery style have better outcomes
post-recovery than those with the latter recovery style (Thompson, McGorry, & Harrigan,
2003).

2.2.2.2!

Relapse

Views vary on whether vulnerability to relapse risk can impact recovery. These views
include: (i) vulnerability of relapse risk does impede recovery; (ii) recovery is possible
and attainable while acknowledging vulnerability to relapse risk; and (iii) recovery is
possible and attainable again after experiencing a relapse (Windell, Norman, & Malla,
2012). These varying views demonstrate that for some, recovery is an end-state whereas
for others it is an ongoing process in which a person oscillates between recovery and
relapse.
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Risk Factors for Relapse
The existing literature suggests that a number of factors are associated with an increased
risk of relapse after a first episode of psychosis, and consequently a decreased chance of
recovery or period of recovery. These include younger age (Hui et al., 2013), younger age
at onset (< 24 years) (Stefanescu et al., 2013), single marital status (Stefanescu et al.,
2013), poor premorbid adjustment (Alvarez-Jimenez et al., 2012), schizophrenia
diagnosis (Hui et al., 2013), schizophrenia load in the family (Stefanescu et al., 2013),
comorbid diagnosis of substance abuse (Malla et al., 2008), persistent substance use
disorder (Alvarez-Jimenez et al., 2012), cannabis use (Bergé et al., 2015), smoking (Hui
et al., 2013), shorter baseline hospitalization (Stefanescu et al., 2013), carer’s critical
comments (Alvarez-Jimenez et al., 2012), poor insight (Bergé et al., 2015), and
medication non-adherence (Alvarez-Jimenez et al., 2012; Hui et al., 2013). Factors
identified to be associated with an early relapse after a first episode of psychosis include
longer first hospitalization, higher severity of negative symptoms at onset, and a longer
duration of untreated psychosis (Stefanescu et al., 2013).

2.2.3!

Empirical Study of Recovery: Recovery Models

The definition, conceptualization, and assessment of recovery has generally been based
on the traditional medical model of recovery or the more recent consumer model of
recovery (Ahmed, Birgenheir, Buckley, & Mabe, 2013; Roe, Mashiach-Eizenberg, &
Lysaker, 2011). The former model is based on the definition of recovery in the scientific
literature and reflects the perspective of the clinician, researcher, or service provider,
while the latter model is based on the definition of recovery in the consumer and
rehabilitation literatures and reflects the patient, service user, or client’s own perspective.
In the traditional model, recovery is conceptualized as an outcome or endpoint and it is
defined as the elimination or reduction of psychotic symptoms and return to pre-illness
levels of function for a certain period of time (Bellack, 2006; Liberman & Kopelowicz,
2005). In the more recent model, recovery is conceptualized as an ongoing process that is
subjective, unique, person-centered (Davidson, O’Connell, Tondora, Staehuli, & Evans,
2005; Silverstein & Bellack, 2008), and it is defined by the person. Therefore, recovery
can be conceptualized as either an outcome or as a process.
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Both models each represent one of the two broad dimensions of recovery: (i) objective
and (ii) subjective (Lysaker, Taylor, Miller, Beattie, Strasburger, & Davis, 2006), with
the former dimension represented by the traditional model and the latter dimension
represented by the newer model (Roe, Mashiach-Eizenberg, & Lysaker, 2011). The
objective and subjective dimensions of recovery are often referred to as objective
recovery and subjective recovery, respectively. In this thesis, we used the terms
subjective recovery and self-perceived recovery interchangeably. A list of other
synonyms for the term subjective recovery is provided in Appendix A.

2.2.4!

Assessment of Recovery as an Outcome

The increased interest in the assessment of recovery as an outcome may perhaps be
attributed to the potential of improving recovery-oriented services directed to promote
and/or sustain recovery following a first episode of psychosis (Drake, Noel, & Deegan,
2015).

2.2.4.1!

Objective Recovery

The assessment of objective recovery in the past has generally been based on the
reduction or elimination of symptoms (Addington, Young, & Addington, 2003; Resnick,
Rosenheck, & Lehman, 2004). More recently, it has been acknowledged that other
objective indicators (or measures) of recovery, aside from or in conjunction with
symptomatic outcomes, need to be taken into account, such as social, functional, or
vocational outcomes (Gee et al., 2016; Kam, Singh, & Upthegrove, 2015; Major et al.,
2010). One such indicator that is increasingly being used is engagement in meaningful
activities such as work and/or school, which is often referred to as vocational outcomes,
vocational activity, or occupational activity (Major et al., 2010; Norman et al., 2007;
Norman et al., 2012). We chose to use occupational activity as an indicator of objective
recovery, defined as engagement in work and/or school on a full-time or part-time basis
in the past year.
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2.2.4.2!

Subjective Recovery

The assessment of subjective recovery in the past has focused on the process, experience,
or meaning of recovery based on first-person accounts of those with first-episode
psychosis (e.g., Connell, Schweitzerder, & King, 2015; de Wet, Swartz, & Chiliza, 2015;
Windell & Norman, 2012; Windell, Norman, & Malla, 2012). The shift towards the
assessment of subjective recovery as an outcome is a relatively new phenomenon, which
can be attested to by the relatively few studies that currently exist in the literature (Law,
Shryane, Bentall, & Morrison, 2015; Morland, 2007; Morrison et al., 2013; Norman,
Windell, Lynch, & Manchanda, 2013) (Table 2.3).
Among the few (n = 4), mostly cross-sectional studies (n = 3) that did assess subjective
recovery as an outcome, albeit with different subjective recovery measures, findings from
these studies suggest that people with first-episode psychosis or experience with
psychosis are more likely to report higher levels of subjective recovery when
experiencing lower levels of the following:
•! Anxiety and depression (Morland, 2007)
•! Negative emotion (Morrison et al., 2013; Law, Shryane, Bentall, & Morrison,
2015)
•! Hopelessness (Law, Shryane, Bentall, & Morrison, 2015)
•! Positive and negative symptoms (Norman, Windell, Lynch, & Manchanda, 2013)
also when experiencing higher levels of the following:
•! Internal locus of control (Morrison et al., 2013)
•! Perceived relational evaluation (Norman, Windell, Lynch, & Manchanda, 2013)
•! Positive self-esteem (Law, Shryane, Bentall, & Morrison, 2015) (Table 2.3)
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Table 2.3: Studies (n = 4) Assessing Subjective Recovery as an Outcome in People with First-Episode Psychosis or Experience
with Psychosis.
Study

Morland
(2007)

Morrison
et al.
(2013)!

Study
Design
CrossSectional

CrossSectional !

Sample Source
(n)
Stand-alone’ Early
Intervention Service
team (n = 54) or
‘Augmented’
Community Mental
Health Team (n = 6)

Early intervention
services (n = 40),
other communitybased mental health
teams (n = 81), & an
inpatient unit (n =
1).!

Sample Size

60 people
with firstepisode
psychosis

122 people
with
experience of
psychosis
!

Variables of Interest
(Measure)
i) General psychopathology
symptoms of anxiety &
depression
ii) Positive symptoms
(hallucinations & delusions)
iii) Negative symptoms
iv) Engagement in paid
employment or education
v) Gender
vi) Age (years) at the time of
interview
vii) Length of time (months)
in service
Psychosocial:
Self-esteem, locus of control,
& emotion
Neuropsychiatric:
Psychotic symptoms,
neurocognition, & insight
!

Subjective
Recovery
Outcome
Measure
Mental Health
Recovery Scale
(MHRS)

Findings

-Significant negative association between anxiety and
subjective recovery.
-Significant negative association between depression
and subjective recovery.
-No significant association between subjective
recovery and the other factors of interest.

Questionnaire
Process of
Recovery (QPR)
& Recovery
Analogue Scale
(RecA)!

-Findings from structural equation modeling indicated
that self-rated recovery from psychosis was directly
influenced by negative emotion (i.e., anxiety,
depression, and negative self-esteem) and internal
locus of control.!

Note: n = count; & = and; PEPP = Prevention and Early Intervention Program for Psychosis; MHRS = Mental Health Recovery Scale; RAS = Recovery
Assessment Scale; MES= Modified Engulfment Scale; QPR = Questionnaire Process of Recovery; RecA = Recovery Analogue Scale.
(Continued)
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Table 2.3: Studies (n = 4) Assessing Subjective Recovery as an Outcome in People with First-Episode Psychosis or Experience
with Psychosis.
Study

Study
Design

Norrman
et al.
(2013)!

CrossSectional!

Law et al.
(2015)

Longitudinal
(6-months)

Sample Source
(n)
Early Intervention
Program (PEPP)!

Early intervention
services (n = 27),
community-based
mental health teams
(n = 45), in-patient
service (n = 1).
Unknown referral
type (n = 37)

Sample Size

84 people
receiving
treatment for
a firstepisode of
psychosis !

110 people
with
experience
of psychosis

Variables of Interest
(Measure)
i) Positive Symptoms
(SAPS)
ii) Negative Symptoms
(SANS)
iii) Social Support (ISEL &
PRES)
!

Negative emotion,
Psychiatric symptoms,
Hopelessness,
Positive self-esteem, and
Functioning

Subjective
Recovery
Outcome
Measure
Recovery
Assessment
Scale (RAS)
& Modified
Engulfment
Scale (MES)!

Questionnaire
Process of
Recovery
(QPR)

Findings

-Significant negative association between positive
symptoms and two or more of the five subscales of the
Recovery Assessment Scale.
- Significant negative association between negative
symptoms and two or more of the five subscales of the
Recovery Assessment Scale.
- Significant positive association between PRES with the
MES, and with each of the subscales of the RAS and
MES. !
-Finding from path analysis indicated that subjective
recovery at 6-months follow-up was negatively
associated with both negative emotion (baseline) and
hopelessness (baseline), and positively associated with
positive self-esteem (baseline).

-Subjective recovery at 6-months follow-up was

negatively associated with psychiatric symptoms
(baseline) and positively associated with functioning
(baseline); however, these associations with subjective
recovery were not as strong as the associations between
the other factors of interest.
Note: n = count; & = and; QPR = Questionnaire Process of Recovery; SAPS = Scale for the Assessment of Positive Symptoms; SANS = Scale for the
Assessment of Negative Symptoms; ISEL = Interpersonal Support Evaluation List; PRES = Perceived Relational Evaluation Scale.
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Comparability of findings of these and future studies assessing subjective recovery as an
outcome is precluded by the lack of a universal gold standard measure. A recent review of
existing subjective recovery measures identified a total of 13 such measures (Shank et al., 2013).
The Maryland Assessment of Recovery in People with Serious Mental Illness Scale (MARS)
(Bellack & Drapalski, 2012) was among the 13 measures identified in the review, which is the
measure used in the current study to assess subjective recovery. The MARS is unique as a
recovery measure because it is the only measure to assess recovery using the Substance Abuse
Mental Health Services Administration (SAMHSA) operational definition of recovery (Ahmed,
Birgenheir, Buckley, & Mabe, 2013) that states:
“Mental health recovery is a journey of healing and transformation enabling a person
with a mental disability to live a meaningful life in the community of his or her choice
while striving to achieve full human potential or personhood.” (SAMHSA, p.1).

2.2.5!

Comprehensive Assessment of Recovery

The relationship between objective and subjective recovery from a first episode of psychosis or
from a psychotic disorder (e.g., schizophrenia) has been examined by several empirical studies
(Jørgensen et al., 2015; Kukla, Lysaker, & Roe, 2014; Lloyd, King, & Moore, 2010; Morland,
2007; Norman, Windell, Lynch & Manchanda, 2013; Resnick, Rosenheck, & Lehman, 2004;
Roe, Mashiach-Eizenberg & Lysaker, 2011). However, findings from these studies have been
inconclusive. Given that there is some evidence suggesting an absence of an association
(Jørgensen et al., 2015; Lloyd, King, & Moore, 2010; Morland, 2007; Norman, Windell, Lynch,
& Manchanda, 2013; Resnick, Rosenheck, & Lehman, 2004), assessment of a person’s recovery
would not be comprehensive and potentially inaccurate if both objective and subjective recovery
are not taken into account. We therefore decided to include both objective and subjective
recovery as outcomes in this thesis.
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2.3! DUP & Recovery: Existing Literature
The duration of untreated psychosis is one of the few most widely studied modifiable risk factors
of poor outcome in people with first-episode psychosis (e.g., Compton et al., 2007; Tang et al.,
2014). With growing research and clinical interest in recovery as an outcome, the impact of the
duration of untreated psychosis on recovery following a first episode psychosis has increasingly
come into focus in recent years.
Our existing knowledge of the association between the duration of untreated psychosis and
recovery has mainly been based on studies with follow-up periods of less than 10-years, and
those conducted in countries other than Canada (Table 2.4). The duration of untreated psychosis
has been reported to be negatively associated with objective recovery (Chang 2012b; Verma,
Subramaniam, Abdin, Poon, & Chong, 2012), and with specific types of objective recovery
including clinical recovery (Chang et al., 2012a; Faber at al., 2011; Winderink, Sytema,
Nienhuis, & Wiersma, 2009), vocational recovery (Major et al., 2010) and psychiatric recovery
(Gumley et al., 2014) (Table 2.4). Interestingly, across different studies, both a shorter and
longer (> 3-months) duration of untreated psychosis has been reported to be negatively
associated with objective recovery, specifically clinical recovery (Chang et al., 2012a; Chang et
al., 2012b) at 3-year follow-up (Table 2.4).
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Table 2.4: Summary of Studies (n = 9) Investigating the Association between DUP and Recovery.
Study
Authors
(Year)!

Wunderink
et al.
(2009)**!

Major et al.
(2010)!

Country!

Netherlands!

London!

Sample
Source!

MESIFOS
(Medication
Strategies In
First Onset
Schizophrenia)
study; Seven
Mental Health
Services!

Early
Intervention
Service !

Length of
Follow-up!

Last 9months of
2-year
period!

Sample
Size at
Followup!
125
Patients
with
FirstEpisode
Psychosis

Follow-up
Rate
n/total (%)!

125/257
(49%)!

!

1 year!

114
Service
Users
with
FirstEpisode
Psychosis!

114/129
(88%)!

Measurement of DUP

Mean
DUP

!
Onset
First
manifestation
of any
positive
psychotic
symptom!

Emergence
of the first
positive
psychotic
symptom!

Endpoint!
Start of
antipsychotic
treatment!

Initiation of
treatment !

Recovery
Dimension
[Objective/
Subjective]

Operational Criteria for
Recovery!

Recovery
Rate
n/total; %!

Presence of an
Association
between DUP
& Recovery
[Yes/No]!

Symptomatic & Functional
Remission
Symptomatic Remission:
Exacerbation of symptoms for
at least 1 week with at least one
relevant PANSS item score
above 3 (mild):P1 (delusions),
P2 (conceptual disorganization),
P3 (hallucinatory behavior), N1
(blunted affect), N4 (social
withdrawal), N6 (lack of
spontaneity), G5
(mannerisms/posturing), and G9
(unusual thought content).
Functional Remission: A patient
should function adequately in
all 7 social roles with none or
only a minimal disability in any
of them (not allowing a score of
2 or 3 on any GSDS role).!
Gaining or returning to
competitive employment
(competitively accessed work,
paid at the market rate) or an
educational activity which
clearly led to a nationally
recognized vocational
qualification or degree, entered
into at any point in the followup period and for any duration.!

24/125;
19.2%
(End of 2year follow up period)!

Presence of a
statistically
significant
association
between DUP
and clinical
recovery.
[Yes]

!
Recovered
= 31.8 days

Clinical
[Objective]!

Nonrecovered =
320.9 days!

86 days
(median)!

Vocational
[Objective]!

Not
Specified!

Absence of a
statistically
significant
association
between DUP
and vocational
recovery during
1-year follow-up.
[No]

!

Note: ** Recovery was assessed before the end of the follow-up period; DUP = Duration of Untreated Psychosis; n = count; GSDS = Groningen Social Disabilities Schedule; PANSS = Positive and Negative Syndrome Scale;
P = Positive Scale; N = Negative Scale; G = General Psychopathology Scale; & = and; % = Percentage.
!

(Continued)
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Table 2.4: Summary of Studies (n = 9) Investigating the Association between DUP and Recovery.
Study
Authors
(Year)!

Albert et al.
(2011)!

Country!

Denmark!

Sample
Source!

OPUS trial;
Inpatient &
Outpatient
Mental Health
Services!

Length of
Follow-up!

5 years!

Sample
Size at
Followup!
255
Patients
with
FirstEpisode
NonAffective
Psychosis!

Follow-up
Rate
n/total (%)!

255/468
(54%)!

Measurement of DUP

Mean
DUP

!
Onset
Not
Specified!

Endpoint!
Onset of
adequate
treatment!

Recovery
Dimension
[Objective/
Subjective]

!

Recovery
Rate
n/total; %

Presence of an
Association
between DUP
& Recovery
[Yes/No]!

Recovery was defined as
40/255;
Absence of a
working or studying, having a
15.7%!
statistically
GAF-function score of 60 or
significant
!
!
Nonabove, having remission of
association
Recovered
negative and psychotic
between DUP
= 121
symptoms, and not living in a
and recovery at
weeks!
supported housing facility or
5-year followbeing hospitalized during the
up.
last 2 years.!
[No]!!
Faber et al.
Netherlands! Add onto
2 years!
45
45/125
First
Start of
Recovered
Clinical
Symptomatic & Functional
9/45;
Presence of a
(2011)!
MESIFOS
Patients
(36%)!
manifestation
antipsychotic
= 34 days
[Objective]!
Remission
20%
statistically
(Medication
with
of any
treatment!
Symptomatic Remission:
significant
!
Strategies In
Nonpositive
NonAn exacerbation of symptoms
association
First Onset
Affective
psychotic
recovered =
for at least 1 week with at
between DUP
Schizophrenia)
Firstsymptom!
294 days
least one relevant PANSS
and clinical
study; Seven
Episode
item score above 3 (mild):P1
recovery.
Mental Health
Psychosis!
(delusions), P2 (conceptual
[Yes] !
Services for
disorganization), P3
Psychosis!
(hallucinatory behavior), N1
(blunted affect), N4 (social
withdrawal), N6 (lack of
spontaneity), G5
(mannerisms/posturing), and
G9 (unusual thought content).
Functional Remission:
Function adequately in all
social roles (Self-care,
Housekeeping, Family
relationships, Partner
relationships, Community
integration, Relationship with
peers, Vocational role &
Parental role) with none or
only a minimal disability in
any of them (not allowing a
score of 2 or 3 on any GSDS
role).!
Note: DUP = Duration of Untreated Psychosis; n = count; GSDS = Groningen Social Disabilities Schedule; GAF-F = Global Assessment of Functioning-Functioning Scale; PANSS = Positive and Negative Syndrome Scale; P =
Positive Scale; N = Negative Scale; G = General Psychopathology Scale; & = and; % = Percentage.

Recovered
= 92 weeks

Operational Criteria for
Recovery!

Not
Specified
[Objective]!

(Continued)
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Table 2.4: Summary of Studies (n = 9) Investigating the Association between DUP and Recovery.
Study
Authors
(Year)!

Chang et al.
(2012a)!

Chang et al.
(2012b)!

Country!

Hong Kong!

Hong Kong!

Sample
Source!

EASY
programme
(Early
Assessment
Service for
Young People
with
Psychosis);
Early
Intervention
Program!

EASY
programme;
Early
Intervention
Program!

Length of
Follow-up!

3 years!

3 years!

Sample
Size at
Followup!

Follow-up
Rate
n/total (%)!

539
Chinese
people
with
FirstEpisode
Psychosis!

539/700
(77%)!

700
Chinese
people
with
FirstEpisode
Psychosis!

700/839
(83%)!

1175
Patients
with
FirstEpisode
Psychosis

1175/1718
(68%)

Measurement of DUP

Mean
DUP

!
Onset
Onset of
positive
psychotic
symptoms!

Onset of
positive
psychotic
symptoms!

Endpoint!
First
contact
with the
psychiatric
service
(EASY
programme)!

First
contact to
psychiatric
service!

226.3 days!

DUP < 3
months =
30.1 days
(n = 346)

Recovery
Dimension
[Objective/
Subjective]

Operational Criteria for Recovery!

Recovery
Rate
n/total; %

Presence of an
Association
between DUP
& Recovery
[Yes/No]!

94/539;
17.4%!

Presence of a
statistically
significant
association
between shorter
DUP (< 3
months) and
recovery.
[Yes]!

!
Clinical
[Objective]!

Not
Specified
[Objective]!

DUP >3
months =
444.8 days
(n = 354)

Symptomatic & Functional
Remission
Recovery: Simultaneous fulfillment
of the following criteria in the last 12
months of study period: (i) CGI-S
scores < 3 for both positive and
negative symptoms; (ii) no
psychiatric admission; (iii) achieving
functional remission. Functional
remission was defined as attaining
both sustained employment (fulltime or part-time work/study) and
SOFAS score > 60 in the last 12
months of the follow-up period.!
Symptom Remission &
Full-Time Employment Status
Recovery: Maintaining CGI-S scores
<3 for both positive and negative
symptoms and full-time employment
status for at least 12 consecutive
months after treatment initiation. !

Not
Specified!

Presence of a
statistically
significant
association
between long
DUP (> 3
months) and
recovery.
[Yes]

!
Verma et al.,
(2012)

Singapore

Early
Psychosis
Intervention
Programme

Presence of a
statistically
significant
association
between shorter
DUP and
recovery at 2year follow-up.
[Yes]
Note: DUP = Duration of Untreated Psychosis; n = count; CGI-S = Clinical Global Impression-Severity of Illness Scale; SOFAS = Social Occupational Functioning Assessment Scale; EASY = Early Assessment Service for Young

People with Psychosis; & = and; % = Percentage.

2 years

Onset of
psychotic
symptoms
(delusions,
hallucinations,
disorganized
behavior)

Definitive
diagnosis
and
treatment
established

16.2
months

Not
Specified
[Objective]

Symptomatic & Functional
Remission
Recovery: Meeting criteria for both
symptomatic & functional remission;
Criteria for symptomatic remission
as proposed by the Schizophrenia
Working Group, that is,
achieving……(continued) !

345/1175;
29.4%

(Continued)!
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Table 2.4: Summary of Studies (n = 9) Investigating the Association between DUP and Recovery.
Study
Authors
(Year)!

Country!

Sample
Source!

Length of
Follow-up!

Sample
Size at
Followup!

Follow-up
Rate
n/total (%)!

Measurement of DUP

!
Onset

(Continued)!

Austin et al.
(2013)*

!

--!

Denmark!

--!

OPUS trial;
Inpatient &
Outpatient
Mental Health
Services!

--!

10 years!

--!

--!

304
People
with
FirstEpisode
Psychosis!

304/496
(61%)!

Mean
DUP

--!

Not
Specified!

Not
Specified!

Operational Criteria for
Recovery!

Recovery
Rate
n/total; %

!

Endpoint!

--!

Recovery
Dimension
[Objective/
Subjective]

--!

--!

Recovered
= 30.79
weeks
(median)

Not
Specified
[Objective]!

Nonrecovered =
50.43
weeks
(median)

and maintaining a PANSS rating
of three or less for a duration of
at least 6-months on the
following items: Delusions (P1),
unusual thought contents (G9),
hallucinatory behaviour (P3),
conceptual disorganization (P2),
mannerisms (G5), blunted affect
(N1), social withdrawal (N4) and
lack of spontaneity (N6) (7).
Functional remission was defined
as having a GAF disability score
of >61 with engagement in ageappropriate vocation (gainfully
employed or studying) at 2 years.!
Full Recovery = Stable remission
of both negative and positive
symptoms, no psychiatric
admissions to hospital or living
in supported accommodation for
the past two years, currently
engaged in work or study and a
GAF-F score of over 60
(Liberman & Kopelowicz, 2005).

--!

14% fully
recovered
60/304;
20%
functionally
recovered!

Presence of an
Association
between DUP
& Recovery
[Yes/No]!

--!

Absence of a
statistically
significant
association
between DUP
and recovery.
[No]!

Functional Recovery = Currently
engaged in work/study, a GAF-F
score over 60, and no psychiatric
hospitalizations or living in
supported accommodation for the
past two years (Albert et al.,
2011) !
Note: * Length of follow-up was 10 years or more. DUP = Duration of Untreated Psychosis; n = count; GAF = Global Assessment of Functioning Scale; GAF-F = Global Assessment of Functioning-Functioning Scale; PANSS =
Positive and Negative Syndrome Scale; P = Positive Scale; N = Negative Scale; G = General Psychopathology Scale; & = and; % = Percentage.

(Continued)
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Table 2.4: Summary of Studies (n = 9) Investigating the Association between DUP and Recovery.
Study
Authors
(Year)!

Gumley et al.
(2014)!

Country!

United
Kingdom!

Sample
Source!

National
Health Service
(NHS) Mental
Health Services!

Length of
Follow-up!

1 year!

Sample
Size at
Followup!
68
People
with
FirstEpisode
Psychosis!

Follow-up
Rate
n/total (%)!

68/79
(86%)!

Note: DUP = Duration of Untreated Psychosis; n = count; & = and; % = Percentage.!

Measurement of DUP

Mean
DUP

!
Onset
Onset of
psychotic
symptomatology!

Endpoint!
Onset of
treatment!

44.37 weeks!

Recovery
Dimension
[Objective/
Subjective]

Operational Criteria for
Recovery!

Recovery
Rate
n/total; %

Presence of an
Association
between DUP
& Recovery
[Yes/No]!

Positive & Negative
Symptoms

Not
Specified!

Presence of a
statistically
significant
association
between DUP
and psychiatric
recovery at 1year follow-up.
[Yes]!

!
Psychiatric
[Objective]!

!
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Our understanding of the relationship between the duration of untreated psychosis and the
other dimension of recovery, subjective recovery, is limited because no study to date has
examined the association between these two variables among people with a first episode
of psychosis (Tables 2.3 & 2.4).

2.4! Knowledge Gaps in Existing Literature
The duration of untreated psychosis appears to be a widely studied modifiable risk factor
of poor outcome in people with first-episode psychosis. It has been a target of early
intervention programs because of evidence that shortening the duration of untreated
psychosis consequently results in better outcomes. However, whether these beneficial
gains are sustained over the long-term is not well known because of the limited number
of prospective studies with follow-up periods of ten years or more.
With recovery emerging as an outcome of interest, the association between the duration
of untreated psychosis and recovery, specifically objective recovery, has increasingly
been examined. However, no study to date has examined the association between the
duration of untreated psychosis and subjective recovery.
Furthermore, all studies to date that have examined the association between duration of
untreated psychosis and long-term outcomes (>10-years) including recovery have been
conducted in countries outside of Canada.

2.5! Conceptual Framework
We constructed a conceptual framework (Figure 2.3) to help visualize the relationships
among the variables and to help identify which variables to treat as potential confounding
variables in our pre-planned multivariable regression analyses. The inter-relationships
between each of the variables in the context of people with first-episode psychosis are
described below and are depicted within the conceptual framework.
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Figure 2.3: Conceptual Framework. Visual Depiction of the Relationships between the Exposure, Outcomes, and Potential
Confounding Variables. Note: Self-Perceived Recovery = Self-Perceived Recovery Score.
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Exposure
Duration of Untreated Psychosis
A long duration of untreated psychosis has been reported to be associated with an
increased risk for relapse (Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013), an
earlier age of onset (Ehmann et al., 2014), an insidious mode of onset (Compton, Chien,
Leiner, Gouldstring, & Weiss, 2008; Morgan et al., 2006), poor premorbid adjustment
(Bechard-Evans, Schmitz, Abadi, Joober, King, & Mallla, 2007; Schimmelmann, Huber,
Lambert, Cotton, McGorry, & Conus, 2008), schizophrenia-spectrum diagnosis
(Bechard-Evans, Schmitz, Abadi, Joober, King, & Mallla, 2007), poor social support
(Comptom & Broussard, 2011), and greater positive and negative symptom severity (Hill
et al., 2012). Furthermore, a long duration of untreated psychosis may result from the
misattribution of positive symptoms of psychosis to the experience of ‘being high.’
Outcomes
Occupational Activity
Employment had been found to be a protective factor for relapse (Sariah, Outwater, &
Malima, 2014). In addition, engagement in paid employment or education, both activities
that hold social status can contribute to a greater sense of one’s self-perceived recovery
(Windell & Norman, 2012). Furthermore, increased engagement in occupational activity
has been reported to be associated with social support (Norman et al., 2007).
Unemployment and/or lower educational level has been reported to be associated with
drug use (Mishra, Ojha, Chapagain, & Tulachan, 2014), increased risk for relapse
(Chabungbam, Avasthi, & Sharan, 2007), and medication non-adherence (Leclerc, Noto,
Bressan, & Brietzke, 2015).
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Potential Mediator
Relapse
A higher risk for relapse has been found to be associated with a long duration of
untreated psychosis (Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013), medication
non-adherence (Alvarez-Jimenez et al., 2012), poorer premorbid adjustment (AlvarezJimenez et al., 2012), schizophrenia-spectrum diagnosis (Hui et al., 2013), unemployment
(Chabungbam, Avasthi, & Sharan, 2007), drug use (Bergé et al., 2015; Hui et al., 2013;
Wade, Harrigan, Edwards, Burgess, Whelan, & McGorry, 2006), early age of onset
(Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013), single marital status (Stefanescu,
Macrea, Popescu, Ilies, & Miclutia, 2013), and lower self-perceived recovery (Windell,
Norman, & Malla, 2012). A decreased risk of relapse has been found to be associated
with social support (Norman et al., 2005). In addition, males have been reported to have
higher relapse rates than females (Ochoa, Usall, Cobo, Labad, & Kulkarni, 2012).
Potential Confounding Variables
Gender
As compared to females, males tend to have an earlier age of onset (Ochoa, Usall, Cobo,
Labad, & Kulkarni, 2012), greater drug use (Arranz et al., 2015), exhibit more negative
symptoms (Køster, Lajer, Lindhardt, & Rosenbaum, 2008; Thorup et al., 2014), are less
likely to be engaged in education (Thorup et al., 2014), are less compliant with
medication (Køster, Lajer, Lindhardt, & Rosenbaum, 2008; Thorup et al., 2014), have
higher relapse rates (Ochoa, Usall, Cobo, Labad, & Kulkarni, 2012), and poorer
premorbid adjustment (Ochoa, Usall, Cobo, Labad, & Kulkarni, 2012).
Age of Onset
An earlier age of onset has been shown to be associated with being male (Ochoa, Usall,
Cobo, Labad, & Kulkarni, 2012), medication non-adherence (Coldham, Addington, &
Addington, 2002), a long duration of untreated psychosis (Ehmann et al., 2014),
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increased risk for relapse (Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013), and
drug use. (Tosato et al., 2013)
Mode of Onset
An insidious mode of onset has been reported to be associated with a long duration of
untreated psychosis (Compton, Chien, Leiner, Gouldstring, & Weiss, 2008; Morgan et
al., 2006).
Premorbid Adjustment
Poor premorbid adjustment has been reported to be associated with a long duration of
untreated psychosis (Bechard-Evans, Schmitz, Abadi, Joober, King, & Malla, 2007;
Schimmelmann, Huber, Lambert, Cotton, McGorry, & Conus, 2008), being male (Ochoa,
Usall, Cobo, Labad, & Kulkarni, 2012), medication non-adherence (Coldham,
Addington, & Addington, 2002), and increased risk for relapse (Alvarez-Jimenez et al.,
2012). In addition, poor premorbid adjustment has been identified as an early sign of
schizophrenia (Gureje, Aderibigbe, Olley, & Bamidele, 1994; Schmael et al., 2007).
Diagnosis of Schizophrenia-Spectrum
A diagnosis of schizophrenia-spectrum has been reported to be associated with a long
duration of untreated psychosis (Bechard-Evans, Schmitz, Abadi, Joober, King, & Malla,
2007), an increased risk for relapse (Hui et al., 2013), greater likelihood of discontinued
use of antipsychotic medication compared to people diagnosed with another type of firstepisode psychotic disorder (Hui et al., 2013). An early sign of schizophrenia is poor
premorbid adjustment (Gureje, Aderibigbe, Olley, & Bamidele, 1994; Schmael et al.,
2007).
Positive Symptoms
Greater positive symptom severity has been shown to be associated with a long duration
of untreated psychosis (Hill et al., 2012). It has also been reported that alleviation or
elimination of symptoms contribute to a greater sense of self-perceived recovery
(Windell & Norman, 2012; Windell, Norman, & Malla, 2012).
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Negative Symptoms
Greater negative symptom severity has been shown to be associated with a long duration
of untreated psychosis (Hill et al., 2012). Furthermore, males tend to exhibit more
negative symptoms than females (Køster, Lajer, Lindhardt, & Rosenbaum, 2008; Thorup
et al., 2014). It has also been reported that alleviation or elimination of symptoms
contribute to a greater sense of self-perceived recovery (Windell & Norman, 2012;
Windell, Norman, & Malla, 2012).
Socioeconomic Status
The education variable in the conceptual framework refers to highest level of education,
which was used as a proxy measure for socioeconomic status. Males are less likely than
females to be engaged in education (Thorup et al., 2014), which in turn can diminish their
ability to attain a well-paying job, generally speaking. A lower socioeconomic status may
also diminish one’s sense of self-perceived recovery because of the difficulty in engaging
in meaningful activities or achieving goals due to limited funds.
Medication Non-Adherence
Medication non-adherence has been reported to be associated with drug use (Miller,
Ream, McCormack, Gunduz-Bruce, Sevy, & Robinson, 2009), increased risk for relapse
(Alvarez-Jimenez et al., 2012; Hui et al., 2013), being male (Køster, Lajer, Lindhardt, &
Rosenbaum, 2008; Thorup et al., 2014), an earlier age of onset (Coldham, Addington, &
Addington, 2002), schizophrenia-spectrum diagnosis (Hui et al., 2013), poorer premorbid
adjustment (Coldham, Addington, & Addington, 2002), poor social support (Rabinovitch,
Bechard-Evans, Schmitz, Joober, & Malla, 2009), and unemployment or lower education
level (i.e., poor occupational activity) (Leclerc, Noto, Bressan, & Brietzke, 2015). In
addition, medication non-adherence has been reported to be essential for one’s sense of
self-perceived recovery (Windell, Norman & Malla, 2012).
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Social Support (Perceived)
Social support has been reported to be associated with a decreased risk of relapse and
increased engagement in occupational activity (Norman et al., 2005). In addition, social
support has also been cited as an important factor to facilitate recovery from a first
episode of psychosis (Windell & Norman, 2012). Poor social support has been reported
to be associated with a long duration of untreated psychosis (Compton & Broussard,
2011) and medication non-adherence (Rabinovitch, Bechard-Evans, Schmitz, Joober, &
Malla, 2009).

2.6! Detailed Thesis Objectives & Hypotheses
All four objectives of this thesis are visually summarized in the conceptual framework
(Figure 2.3) presented in the previous section. In this section, each of the four objectives
and hypotheses will be described. In addition, the corresponding section of the conceptual
framework depicting each objective will be highlighted using a simplified version of the
conceptual framework. The simplified version includes the exposure, potential mediator,
and outcome variables (Figure 2.4).

Figure 2.4: Simplified Conceptual Framework. Note: DUP = Duration of Untreated
Psychosis; SELF-PERCEIVED RECOVERY = Self-Perceived Recovery Score.
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2.6.1!

Objective 1

Findings from empirical studies that have investigated the relationship between objective
and subjective recovery from psychotic disorders (e.g. schizophrenia) or other serious
mental illness have been equivocal, with evidence for and against the presence of an
association (Jørgensen et al., 2015; Kukla, Lysaker, & Roe, 2014; Lloyd, King, & Moore,
2010; Morland, 2007; Norman, Windell, & Manchanda, 2013; Resnick, Rosenheck, &
Lehman, 2004; Roe, Mashiach-Eizenberg & Lysaker, 2011). Given these inconsistent
findings, we sought to examine the association at 10-year follow-up between
occupational activity (less than 52 weeks of the past year vs. 52 weeks of past year), an
objective measure of recovery, and self-perceived recovery score, a subjective measure of
recovery, among people 16 to 50 years of age who experienced a first episode of
psychosis (Figure 2.5).

Figure 2.5: Objective 1 depicted within the Simplified Conceptual Framework. Note:
DUP = Duration of Untreated Psychosis; SELF-PERCEIVED RECOVERY = SelfPerceived Recovery Score.
Hypothesis 1
We hypothesized that there would be a statistically significant positive association
between occupational activity (i.e., objective recovery) and self-perceived recovery score
(subjective recovery) at 10-year follow-up, such that people who engaged in occupational
activity for 52 weeks of the past year would have higher self-perceived recovery scores.
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2.6.2!

Objective 2

The study conducted by Austin and colleagues (2013) is the only study to date that has
investigated whether the duration of untreated psychosis is associated with objective
recovery among people with first-episode psychosis over a long follow-up period (>10years). To add to this essentially non-existent body of literature, we sought to investigate
whether duration of untreated psychosis is associated with occupational activity (i.e.,
objective recovery) among people 16 to 50 years of age, 10-years after being treated for a
first episode of psychosis, adjusting for gender, age of onset, and other confounding
variables (Figure 2.6).

Figure 2.6: Objective 2 depicted within the Simplified Conceptual Framework. Note:
DUP = Duration of Untreated Psychosis; SELF-PERCEIVED RECOVERY = SelfPerceived Recovery Score.
Hypothesis 2
We hypothesized that a longer duration of untreated psychosis would decrease the odds
of engagement in occupational activity, adjusting for gender, age of onset, and other
confounding variables.
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2.6.3!

Objective 3

To our knowledge, no study to date has examined the association between the duration of
untreated psychosis and subjective recovery among people with first-episode psychosis.
To address this current gap in the literature, we investigated whether the duration of
untreated psychosis is associated with self-perceived recovery score (i.e., subjective
recovery) among people 16 to 50 years of age, 10-years after being treated for a first
episode of psychosis, adjusting for gender, age of onset, and other confounding variables
(Figure 2.7).

Figure 2.7: Objective 3 depicted within the Simplified Conceptual Framework. Note:
DUP = Duration of Untreated Psychosis; SELF-PERCEIVED RECOVERY = SelfPerceived Recovery Score.
Hypothesis 3
We hypothesized that there will be a statistically significant negative association between
the duration of untreated psychosis and self-perceived recovery score (i.e., subjective
recovery), such that longer duration of untreated psychosis would be associated with
lower self-perceived recovery scores, after adjusting for gender, age of onset, and other
confounding variables.
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2.6.4!

Objective 4

Vulnerability to relapse has been found to be associated with a long duration of untreated
psychosis (Saravanan et al., 2010; Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013),
and it has also been perceived, by some, to be a barrier to one’s recovery from a firstepisode of psychosis (Maddigan, 2011; Windell, Norman, & Malla, 2012). We thus
sought to investigate whether relapse mediates the relationship between the duration of
untreated psychosis and self-perceived recovery score among people 16 to 50 years of
age who experienced a first episode of psychosis, adjusting for gender, age of onset, and
other confounding variables (Figure 2.8).

Figure 2.8: Objective 4 depicted within the Simplified Conceptual Framework. Note:
DUP = Duration of Untreated Psychosis; SELF-PERCEIVED RECOVERY = SelfPerceived Recovery Score.
Hypothesis 4
We hypothesized that relapse will mediate the relationship between the duration of
untreated psychosis and self-perceived recovery score (i.e., subjective recovery), such
that a longer duration of untreated psychosis would be associated with greater relapse,
which in turn would result in lower self-perceived recovery scores, after adjusting for
gender, age of onset, and other confounding variables.
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Chapter 3!!

3!

Methods

In this chapter, the data source is described in Section 3.1, followed by the study
procedure for the follow-up assessments conducted at 10-years (i.e., 10-year follow-up
study) in Section 3.2. In Section 3.3, the process to obtain access to the data of the source
study will be discussed. Thereafter in Section 3.4, a description of the observations and
variables used in the statistical analyses will be provided. Next in Section 3.5, missing
data and the method to handle missing data will be described. Lastly, the statistical
analysis plan will be described in Section 3.6.

3.1! Data Source
As mentioned in Chapter 1, this thesis used data from a prospective cohort study that
assessed outcomes of clients 10-years following initial treatment for a first episode of
psychosis, received from an early intervention program (PEPP; London, Canada). This
study titled, “Assessment of 10 Year Outcomes for Clients of the Prevention and Early
Intervention Program for Psychoses (PEPP)” received ethics approval from Western
University’s Ethics Board for Health Sciences Research. No further ethics approval for
this thesis was required since our objectives fell within the scope of the objectives of the
prospective cohort study.
PEPP is a comprehensive early psychosis intervention program that has been in operation
since 1997 (Malla, Norman, McLean, Scholten, & Townsend, 2003; Norman &
Manchanda, 2016), located in Zone A, on the 2nd floor of Victoria Hospital, London
Health Sciences Centre (LHSC). This program is designed to treat non-affective firstepisode psychotic disorders, and has an open referral policy, which allows family
members, individuals, and concerned persons (e.g., teacher) to make a referral. A
physician referral is not required (Norman & Manchanda, 2016; www.PEPP.ca).
Admission to PEPP is restricted to people who: 1) Are between the ages of 16 and 50
years; 2) Are experiencing symptoms of a first-episode non-affective psychotic disorder;
3) Have never been treated for psychosis or have taken antipsychotic medication for no
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more than one month; 4) Do not suffer from organic brain damage, pervasive
developmental disorder, epilepsy, or other brain disorders or injuries; 5) Have no current
outstanding legal matters, such that contact with forensic psychiatric services is needed;
and 6) Who live within the predominantly urban catchment area of Middlesex County
and the city of London (www.PEPP.ca). People who meet these admission criteria are
rapidly admitted to PEPP since this program does not have a waiting list (Norman &
Manchanda, 2016).
Following admission to PEPP, an individualized treatment plan is created in collaboration
with the client, family (if applicable), and with other professionals involved in the client’s
care including, but not limited to, a case manager, psychiatrist, or psychologist (Norman
& Manchanda, 2016; www.PEPP.ca). The treatment plan includes medical management,
psychosocial management, and case management (Malla, Norman, McLean, Scholten, &
Townsend, 2003; Norman & Manchanda, 2016). Medical management refers to treatment
by low-dose antipsychotic medication (primarily second-generation), prescribed by a
psychiatrist to the client on a regular basis (Manchanda, Norman, Malla, Harricharan, &
Northcott, 2008). Psychosocial management refers to treatment with psychosocial
interventions such as individual supportive psychotherapy (i.e., cognitive behavioural
therapy) (Malla, Norman, McLean, Scholten, & Townsend, 2003; Norman &
Manchanda, 2016). Lastly, case management refers to treatment in the form of support
and advocacy by one’s case manager. The case manager coordinates care, develops goals,
and ensures the needs of the client are being met, among many other functions (Malla,
Norman, McLean, Scholten, & Townsend, 2003; www.PEPP.ca).
The treatment plan is structured around a modified case management model in which
intensity of treatment is determined by the stage of a client’s illness, the client’s needs,
and the needs of the client’s family (Malla, Norman, McLean, Scholten, & Townsend,
2003). Each client will receive intense treatment for a minimum of two-years and up to a
period of five-years (Malla, Norman, McLean, Scholten, & Townsend, 2003; Norman &
Manchanda, 2016). Intense treatment involves the client receiving all forms of treatment
offered by PEPP. At the end of the two-year treatment period, the clinical status of the
client is assessed to determine whether to provide him or her with extended treatment in

51

the form of both medication management and case management (one- to three-years) or
to provide less intense treatment in the form of medication management only (Malla,
Norman, McLean, Scholten, & Townsend, 2003; Norman, Manchanda, Malla, Windell,
Harricharan, & Northcott, 2011). Throughout the two to five-year period, the clinical
status of the client is assessed every three to six months to determine whether to provide
the client with greater or lesser treatment (Norman, Manchanda, Malla, Windell,
Harricharan, & Northcott, 2011).

3.2! Study Procedure
The prospective cohort study (i.e., source study) collected data from clients at baseline, 5year follow-up, and again at 10-year follow-up. We will focus our discussion of study
procedures pertaining mainly to the follow-up assessment conducted 10-years following
initial treatment for first-episode psychosis at PEPP.

3.2.1!

Participant Recruitment

Between March 1997 and February 2002, a total of 132 people were admitted to PEPP.
Each person provided informed consent to which he or she agreed to be followed-up for
outcome assessments even if he or she was no longer receiving treatment at PEPP, as
described in the letter of information (Malla et al., 2002; Norman, Manchanda, Malla,
Windell, Harricharan & Northcott, 2011).
The eligibility criteria to take part in the source study were the same as the admission
criteria for PEPP (Section 2.1). Additional eligibility criteria for participation in the study
included: 1) Ability to speak or understand English; 2) Competent and willing to provide
written informed consent; 3) Diagnosed with a non-affective psychotic disorder that
meets Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
criteria; and 4) Current Outpatient Status.

3.2.2!

Follow-up Assessments

Between February 2014 and June 2015, the research coordinator at PEPP re-contacted
some of the 132 clients admitted to PEPP between March 1997 and February 2002, with
a request to participate in the 10-year follow-up assessment. Clients were re-contacted if
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at least 10-years had elapsed since receiving initial treatment for a first episode of
psychosis at PEPP. If the client agreed to participate, an assessment interview was
scheduled at a time convenient for the client.

3.2.3!

Assessment Interviews

Participation in the 10-year follow-up assessment involved the completion of an outcome
assessment that included a battery of clinical and non-clinical outcome measures, some of
which were also administered at 5-year follow-up. Completion of the outcome
assessment was split between two assessment interviews that were scheduled a week or
two apart. A random number system was used to determine the order in which outcome
measures were to be administered to the participant in either the first and/or second
assessment interview. The random number system is described in Figure 3.1.

Figure 3.1: Random Number System. Note: Determined the order in which non-clinical
and clinical outcome measures were to be administered during the first and/or second
assessment interview; LTO = Long Term Outcome.

53

When the participant arrived for his or her first assessment interview, written informed
consent was obtained. Demographic information was then obtained from the participant
by use of a demographics questionnaire, and outcome measures were administered in a
semi-structured interview format. Non-clinical outcome measures were administered to
the participant by the research coordinator, who was trained and supervised by a licensed
clinical psychologist. A licensed clinical psychologist or psychiatrist with PEPP
administered all clinical outcome measures to the participant, ensuring a standardized
presentation of study measures. Inter-rater reliability between these two clinicians with
PEPP was good (Interclass correlation coefficient = 0.80). Outcome measures were
administered verbally to participants with literacy or comprehension problems.
As the participant was completing the outcome measures, the interviewer took note of the
participant’s tolerance level, energy level, and level of cognitive functioning. Based on
these factors, the participant may have been encouraged to take a break or to complete the
rest of the interview another day. If a participant did not complete the 10-year assessment
during the first interview, a second assessment interview was scheduled a week or two
later.
Most participants completed the 10-year follow-up assessment over two interviews. Each
assessment interview took between 1 to 1.5 hours to complete. All assessment interviews
were conducted in research offices at PEPP. For each of the assessment interviews,
participants were reimbursed for their time in the amount of $30.00, as well as their travel
expenses in the form of a parking pass or bus tickets. Participants were also provided
with snacks and water at each of the assessment interviews.

3.3! Data Set
3.3.1!

Data Access Process

Obtaining access to data from the prospective cohort study consisted of five steps. The
first step involved having a meeting with the primary investigator of the source study.
The purpose of this meeting was two-fold. First, to determine which studies were
currently being conducted using the same data set, and second, to discuss possible
research questions based on research currently being conducted in the field. The second
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step involved formulating objectives and a statistical plan based on available data. The
third step involved submitting a request for access to a subset of variables, which was
submitted to the primary investigator. The fourth step involved the primary investigator
extracting the requested variables from the main PEPP database containing demographic
and longitudinal outcome data, and creating a data set. The final step of this process
involved the primary investigator transferring the de-identified data set.

3.3.2!

Data Cleaning

Upon receiving the data set, we used Stat/Transfer to convert the data from SPSS format
to Stata format (sav to .dta). We then used Stata, version 14 (StataCorp, 2015) to ‘clean’
the data. This included dropping variables that were not required for pre-specified
analyses, and checking for temporal consistency of data, distributions of all variables, and
for potential outliers. Additional data cleaning included relabeling variables, recoding of
variables, and transforming variables with a skewed distribution.

3.4! Variables & Measures
3.4.1!

Exposure Variable

Duration of Untreated Psychosis
Duration of untreated psychosis was defined as the length of time in weeks between the
date of onset of positive psychotic symptoms (e.g., hallucination) to the date of initiation
of adequate treatment for 1-month. Adequate treatment referred to treatment with
antipsychotic medication for 1-month (or until symptoms have resolved) or psychosocial
treatment (i.e., assertive case management) for 1-month. These dates were extracted from
select items from the CORS as part of the baseline assessment (Norman & Malla, 2002).
The CORS is a semi-structured questionnaire administered at baseline by trained research
assistants. This questionnaire is divided into five main sections: 1) Identifying
Information; 2) Demographic Information; 3) Family Structure and Health; 4) Pathways
to Care; and 5) Topography of Psychotic Episode (TOPE). In completing the CORS,
information was obtained from the client, family, and referring source.
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The CORS has been used in previous first-episode psychosis studies (e.g., Flanagan &
Compton, 2012; Franz et al., 2010; Monte, Golding, & Compton, 2008), and has
demonstrated excellent interrater reliability with ICC’s ranging from 0.86 to 0.90 for the
duration of untreated psychosis and for the duration of untreated illness (Iyer et al.,
2008).
We assessed the distribution of the duration of untreated psychosis, which was observed
to be positively skewed. For comparability of results, we normalized the duration of
untreated psychosis distribution by taking the logarithm to base10 (log10), a routine
approach used by other researchers in the field (e.g., Austin et al., 2013; Gumley et al.,
2014; Norman et al., 2012). For all analyses conducted in this thesis, we used the
duration of untreated psychosis (i.e., transformed version) as a continuous variable.

3.4.2!

Outcome Variables

Self-Perceived Recovery
Self-perceived recovery was assessed at 10-year follow-up using the MARS (Bellack &
Drapalski, 2012), a self-report measure of one’s perceived status of recovery from serious
mental illness. The MARS consists of 25-items, each scored on a 5-point Likert scale
ranging from 1-Strongly Disagree to 5-Strongly Agree. The MARS covers six
components of recovery based on those identified by SAMHSA, including self-direction
(e.g., “I usually know what is best for me.”) or empowerment (e.g., “I have abilities that
can help me reach my goals.”), holistic (e.g., “I feel accepted as who I am.”), non-linear
(e.g., “When I have a relapse, I am sure that I can get back on track.”), strengths-based
(e.g., “My strengths are more important than my weaknesses.”), responsibility (e.g., “I
am responsible for making changes in my life.”), and hope (e.g., “I am hopeful about the
future.”). All six components are considered to be essential to recovery and each domain
exclusively focuses on measureable aspects of the person (Drapalski et al., 2012).
The MARS has demonstrated strong internal consistency for the entire measure (α =
0.95), as well as strong test-retest reliability (α = 0.898) when used with a sample of 166
people with severe mental illness including schizophrenia, schizoaffective disorder,
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bipolar I disorder, or major depression with psychotic features (Drapalski et al., 2012).
This empirical measure can be used for both research and clinical purposes (Bellack &
Drapalski, 2012).
For the purpose of this thesis, we used the total MARS score as an overall assessment of
self-perceived recovery. Total scores on this uni-dimensional measure range from 25 to
125. Higher scores are indicative of greater self-perceived recovery from severe mental
illness. Self-perceived recovery score was used as a subjective measure of recovery. We
used self-perceived recovery score at 10-year follow-up as a continuous variable in all
analyses.
Occupational Activity
Occupational activity included engagement in work and/or school on a full-time or parttime basis in the past year. This was assessed at 10-year follow-up using items from the
Life Chart Schedule (LCS) (WHO, 1992), which was designed to assess the long-term
outcomes and course of schizophrenia in four domains: Symptoms, treatment, residence,
and work (Sartorius, Gulbinat, Harrison, Laska, & Siegel, 1996). Specifically, we used
items 2, 3, 10, and 11 of the 16-item modified “Work & Disability” subscale. Items 2
(“Weeks in full-time jobs.”) and 3 (“Weeks in part-time jobs.”) were used to assess the
number of weeks during the past year the participant was employed full-time or parttime. Items 10 (“Weeks as full-time student.”) and 11 (“Weeks as part-time student.”)
were used to assess the number of weeks during the past year the participant attended
school on a full-time or part-time basis.
We generated the occupational activity variable by summing together responses for Items
2 (“Weeks in full-time jobs.”), 3 (“Weeks in part-time jobs.”), 10 (“Weeks as full-time
student.”), and 11 (“Weeks as part-time student.”) of the 16-item modified “Work and
Disability” subscale of the LCS. We followed the approach that Norman and colleagues
(2007; 2012) have used to compute and assess occupational activity among people with
first-episode psychosis. However, we additionally included engagement in work and/or
school on a part-time basis. Psychometric information for the use of this approach was
not available.
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We assessed the distribution of weeks of occupational activity, which was observed to be
bimodal. We therefore decided to dichotomize weeks of occupational activity by using
the median as the cut-point. Thus, participants were engaged in occupational activity for
either 52 weeks of the past year or for less than 52 weeks of the past year. Occupational
activity was used as an objective measure of recovery. We used occupational activity at
10-year follow-up as a dichotomous variable in all analyses.

3.4.3!

Mediator Variable

Relapse
We used number of hospitalizations for a mental health reason, as derived from medical
charts, as a proxy indicator for relapse. Number of hospitalizations were extracted from
baseline to 5-year follow-up (time 1) and from 5-year follow-up to 10-year follow-up
(time 2). The number of hospitalizations at time 2 were used in the mediation analysis.
A more accurate measure of relapse is the recurrence of the positive symptoms of
psychosis, however, these data were not collected between the 5- and 10-year follow-up
periods. Nonetheless, hospitalization data are a sensitive (87%), yet, non-specific (47%)
indicator of relapse among people with first-episode psychosis (Addington, Patten,
McKenzie, & Addington, 2013).

3.4.4!

Potential Confounding Variables

For all analyses, we adjusted for 11 of the 13 variables we identified as potential
confounders in our conceptual framework (Chapter 2). A description of the interrelationships among the exposure variable, the two outcome variables, the mediator
variable, and the potential confounding variables is provided in Chapter 2. A rationale for
why we did not adjust for two of the potential confounding variables in all analyses is
provided in this section.
Gender
Gender was assessed at baseline using the demographics questionnaire, with response
options of either Male or Female.
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Age of Onset
Age of onset refers to one’s chronological age at the time of the first onset of psychotic
symptoms (e.g., hallucinations) (Norman et al., 2007). To calculate age of onset, date of
birth and date of first change were obtained from the TOPE section of the CORS
(Norman & Malla, 2002). At baseline, information for the CORS was obtained from
patient reports and combined with any information provided by the family and referral
source. We used age of onset as a continuous variable in all analyses.
Mode of Onset
Mode of onset refers to how quickly psychotic symptoms develop over the course of a
first episode of psychosis (Compton, 2010). Mode of onset was calculated by subtracting
date of onset of psychosis (day/month/year) from date of first change (day/month/year),
which were obtained from the CORS (Norman & Malla, 2002). At baseline, information
was obtained from patient reports and combined with any information provided by the
family and referral source.
Mode of onset was used as a dichotomous variable in all analyses, with participants
labelled with insidious or acute mode of onset. An insidious mode of onset was defined
as equal or greater to 1-month, and an acute mode of onset defined as less than 1-month.
Diagnosis of a Psychotic Disorder
A primary diagnosis of a non-affective psychotic disorder was made at baseline using the
Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCIDCV) (First, Spitzer, Gibbon, & Williams, 1995). The SCID-CV is a semi-structured
interview that was administered by trained research assistants and cross-checked with the
treating clinician. In completing the SCID-CV, information was obtained from various
sources including client report, information provided by family, and any available
medical records.
The SCID-CV is comprised of three main sections: 1) Overview; 2) Modules A to F; and
3) Diagnostic Summary. The modules section of the SCID-CV is used for the purposes of
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making a diagnosis. This section is comprised of six modules corresponding to six
diagnostic categories: A) Mood Episodes (69-items); B) Psychotic and Associated
Symptoms (15-items); C) Differential Diagnosis of Psychotic Disorders (39-items); D)
Mood Disorders (19-items); E) Alcohol and Other Substance Use Disorders (32-items);
and F) Anxiety and Other Disorders (91-items). Modules C and D were used to make a
diagnosis of a psychotic disorder.
Items within each module correspond to specific criteria or symptoms of a specific
disorder. Items are rated according to one of the two response ratings: 1) Inadequate
information (?), Absent/Subthreshold (-), Present (+); or 2) Yes/No. Some items are
skipped depending on how that item was rated. For each disorder, a certain number of
criteria/symptoms or certain criteria/symptoms must be present (rated as either + or Yes)
in order to be diagnosed with a particular disorder.
We dichotomized diagnosis into schizophrenia-spectrum or other psychotic disorder.
We categorized the following diagnoses as schizophrenia-spectrum: SchizophreniaDisorganized; Schizophrenia-Paranoid; Schizophreniform; Schizoaffective; and
Schizophrenia-Undifferentiated. We then categorized the remaining diagnoses as other
psychotic disorder: Substance-Induced Psychosis; Bipolar I with Psychotic Features;
Major Depression with Psychotic Features; Brief Psychotic Disorder; and Psychosis Not
Otherwise Specified.
Premorbid Adjustment
Premorbid adjustment refers to the person’s psychosocial functioning before the onset of
psychotic illness or symptoms (Cannon-Spoor, Potkin, & Wyatt, 1982), and was assessed
at baseline using the Premorbid Adjustment Scale (PAS; Cannon-Spoor, Potkin, &
Wyatt, 1982). The PAS is a rating scale that assesses premorbid adjustment from a
developmental perspective. This scale consists of a general section and four sections
pertaining to distinct developmental age periods including childhood (up to 11 years),
early adolescence (12 to 15 years), late adolescence (16 to 18 years), and adulthood (19
years and above). Within each of the four developmental age periods, all or some of the
following five domains of psychosocial functioning are assessed: 1) Sociability and
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withdrawal; 2) Peer relationships; 3) Scholastic performance; 4) Adaptation to school;
and 5) Ability to form social-sexual relationships. Ability to form social-sexual
relationships is not included nor assessed in the childhood period, while scholastic
performance and adaption to school are not included nor assessed in the adulthood
period. The general section contains items assessing energy level, interest in life,
independence, education, social-personal adjustment, highest level of global functioning
achieved, work (employed for pay, change in work, and frequency of job change), or
school (attendance, functioning, and performance). This section was not completed by
participants in the baseline assessment.
To minimize confounding of onset of illness and premorbid adjustment, ratings from the
late adolescence and adulthood periods were excluded from the analysis because onset of
psychotic or early symptoms generally occurs in late adolescence or early adulthood
(Norman, Malla, & Manchanda, 2007). Thus, ratings of items from the childhood and
early adolescence periods were used to assess premorbid adjustment, specifically items
pertaining to the sociability and scholastic performance domains. Each item was rated on
a Likert-type scale ranging from 0 to 6. For each psychosocial domain assessed in these
age periods, ratings were summed and divided by the total possible rating, resulting in an
index varying between 0 and 6, with higher scores indicating worse adjustment. All
ratings were made with reference to the premorbid period, which ends 6-months before
the onset of positive psychotic symptoms (Cannon-Spoor, Potkin, & Wyatt, 1982).
Ratings were based on information obtained from patient reports and combined with any
information provided by the family and referral source.
With respect to psychometric properties, Brill and colleagues (2008) results support the
predictive and concurrent validity of the PAS when used with 91 males with
schizophrenia or schizoaffective disorder, based on the Pearson correlations between the
PAS (school achievements and school adjustment items) and the Draft Board’s
(functioning in structured environments scale) concurrent ratings (r = 0.71 and r = 0.72)
and ratings obtained again at the age of 17 years (re-administered; r = 0.43 and r = 0.47).
The PAS also demonstrated good scale reliability: Childhood (α = 0.72; four items);
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Early adolescence (α = 0.79; five items); and Late adolescence (α = 0.79; five items)
(Brill, Reichenberg, Weiser, & Rabinowitz, 2008).
We used the overall premorbid adjustment scale rating for childhood and adolescence
(i.e., premorbid adjustment score) as a continuous variable in our descriptive analysis.
We were unable to use this variable in our simple and multivariable regression analyses
because of the lack of variability in the distribution of scores.
Positive Symptoms
The presence and severity of the positive symptoms of psychosis were assessed at
baseline, 5-year follow-up, and 10-year follow-up using the Scale for the Assessment of
Positive Symptoms (SAPS; Andreasen, 1984). The SAPS consists of 34-items, each rated
on a 6-point Likert-type scale ranging from 0-Absent to 5-Severe. The SAPS yields
cumulative ratings and subscale ratings (i.e., global ratings) pertaining to four positive
symptoms: 1) Hallucinations (7 items; e.g., Visual Hallucinations, “The patient sees
shapes or people that are not actually present.”); 2) Delusions (13 items; e.g., Thought
Insertion, “The patient believes that thoughts that are not his or her own have been
inserted into his or her head.”); 3) Bizarre Behaviour (5 items; e.g., Repetitive or
Stereotyped Behaviour, “The patient develops a set of repetitive actions or rituals that he
or she must perform over and over.”); and 4) Positive Formal Thought Disorder (9
items; e.g., “Tangentiality, “Replying to a question in an oblique or irrelevant manner.”).
All ratings were completed with reference to the past month. Cumulative ratings range
from 0 to 170, with higher ratings reflective of a greater severity of positive symptoms.
Global ratings for each positive symptom range from 0 to 20, with higher ratings
reflective of a greater severity of a particular positive symptom.
The SAPS has been used in previous first-episode psychosis studies (e.g., Austin et al.,
2015; Malla et al., 2008; Norman, Malla, & Manchanda, 2007), but specific psychometric
information was not provided.
To obtain a single continuous measure of severity of positive symptoms, we computed a
composite score using the global ratings of each of the four positive symptoms (Noman et
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al., 2012). We used the positive symptoms scores at baseline and 10-year follow-up as
continuous variables in all analyses.
Negative Symptoms
The presence and severity of the negative symptoms of psychosis were assessed at
baseline, 5-year follow-up, and 10-year follow-up using the Scale for the Assessment of
Negative Symptoms (SANS; Andreasen, 1983). The SANS consists of 25-items, each
rated on a 6-point Likert-type scale ranging from 0-Absent to 5-Severe. The SANS yields
cumulative ratings and subscale ratings (i.e., global ratings) pertaining to five negative
symptoms: 1) Affective Flattening or Blunting (8 items; e.g., Affective Nonresponsivity,
“The patient fails to laugh or smile when prompted.”); 2) Alogia (5 items; e.g., Poverty of
Speech, “The patient’s replies to questions are restricted in amount, tend to be brief,
concrete, unelaborated.”); 3) Avolition-Apathy (4 items; e.g., Physical Anergia, “The
patient tends to be physically inert. He or she may sit for hours and not initiate
spontaneous activity.”); 4) Anhedonia-Asociality (5 items; e.g., Ability to Feel Intimacy
and Closeness, “The patient may display an inability to form close or intimate
relationships, especially with opposite sex and family.”); and 5) Attention (3 items;
Social Inattentiveness, “The patient appears uninvolved or unengaged. He or she may
seem spacey.”).
All ratings were completed with reference to the past month. Cumulative ratings range
from 0 to 125, with higher ratings reflective of a greater severity of negative symptoms.
Global ratings for each negative symptom range from 0 to 25, with higher ratings
reflective of a greater severity of a particular negative symptom.
The SANS was initially developed for those with a diagnosis of schizophrenia. However,
a recent study reported that the SANS structure was similar among a sample of people
with first-episode schizophrenia spectrum (n = 191) or non-schizophrenia spectrum (n =
246) diagnoses, thus supporting the use of the SANS among people with first-episode
psychosis (Lyne et al., 2013). The SANS has been used in previous first-episode
psychosis studies (e.g., Austin et al., 2015; Lyne et al., 2013; Malla et al., 2008; Norman,

63

Malla, & Manchanda, 2007), and has been reported to have good psychometric properties
(Lyne et al., 2013); however, specific psychometric information was not provided.
To obtain a single continuous measure of severity of negative symptoms, we computed a
composite score using the global ratings of each of the five negative symptoms (Norman
et al., 2012). We used the negative symptoms scores at baseline and 10-year follow-up as
continuous variables in all analyses.
Highest Level of Education
Highest level of education attained was assessed at 10-year follow-up using the
demographics questionnaire. The response options for highest level of education
included: “No formal schooling completed,” “Elementary School (8th grade),” “Some
High School (no diploma),” “High School graduate or the equivalent (GED),” Some
college or university (no degree/diploma),” “Trade/technical/vocational training,”
“College,” “University,” and “Graduate School.” Information collected on participants’
highest level of education was used as a proxy indicator of socioeconomic status. Based
on the lack of variability in response options, we recoded this variable to allow
participants to be grouped into one of two levels of education: 1) Less than or completed
high school; 2) Some post-secondary or higher.
Social Support (Perceived)
Social support was assessed at 10-year follow-up using the Interpersonal Support
Evaluation List (ISEL; Cohen, Mermelstein, Kamarck, & Hoberman, 1985), a 40-item,
dichotomously scored (Probably True /Probably False) self-report measure of perceived
social support. The ISEL yields total scores and subscale scores assessing four domains
of social support including appraisal (10 items; e.g., “There is at least one person I know
whose advice I really trust.”), tangible (10 items; e.g., “If I needed a quick emergency
loan of $100, there is someone I could get it from.”), self-esteem (10 items; e.g., Most of
my friends are more interesting than I am.”), and belonging (10 items; e.g., “When I feel
lonely, there are several people I could call and talk to.”). The appraisal subscale
measures a person’s perception of having someone to talk to about his or her problems.
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The tangible subscale measures a person’s perception of having someone to provide
material aid. The self-esteem subscale measures a person’s perception of having someone
that will provide positive comparison when comparing him or herself to others. The
belonging subscale measures a person’s perception of having people with whom he or
she can do things with.
The ISEL has demonstrated strong internal consistency (α = 0.93) and high 4-month testretest reliability (r = 0.83) among a sample of 59 people with a diagnosis of bipolar I
disorder (Johnson, Winett, Meyer, Greenhouse, & Miller, 1999). Total scores on this
measure range from 0 to 40. Higher scores are indicative of greater perceived social
support.
To obtain a single continuous measure of perceived social support, we computed a
composite score using the subscale ratings of each of the four domains of social support,
and the perceived social support score was used as a continuous variable in all analyses.
Drug Use
Drug use was assessed at baseline, 5-year follow-up, and 10-year follow-up using the 20item Drug Abuse Screening Test (DAST-20; Skinner, 1982), a self-report measure of
one’s involvement and abuse of drugs in the last 3-months (e.g., “In the last 3 months,
have you used drugs other than those required for medical reasons?”). For the purposes
of the DAST-20, drug use is operationalized as any non-medical use of drugs (i.e., street
drugs). Non-medical use of drugs does not include alcohol.
All 20-items on this uni-dimensional measure are dichotomously scored (Yes/No). A
score of “1” is given for each Yes response, except for items 4 (“Did you get through the
week without using drugs (other than those required for medical reasons)?”) and 5
(“Were you always able to stop using drugs when you want to?”), for which a No
response is given a score of “1.” If the response to item 1 (“Have you used drugs other
than those required for medical reasons?”) and item 2 (“Have you abused prescription
drugs?”) are both “No,” the remaining 18-items are not to be completed. Total scores on
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this measure range from 0 to 20, with higher scores indicating a greater severity of drug
use.
The use of a cut-off score of 3 or above (sensitivity, 85%; specificity; 73%) on the
DAST-20 has been recommended for optimal detection of problem drug use in a sample
of people with first-episode psychosis sampled from an early intervention service, as
compared to the conventional score of 6 or above (sensitivity, 55%; specificity; 86%)
(Cassidy, Schmitz, & Malla, 2008).
The DAST-20 has demonstrated strong internal consistency when used with a sample of
128 people with first-episode psychosis (α = 0.998) (Cassidy, Schmitz, & Malla, 2008),
and has demonstrated good test/retest reliability (ICC = 0.78) when used with a sample of
97 outpatients with an Axis I disorder, other than substance abuse or dependence (e.g.,
schizophrenia) (Cocco & Carey, 1998).
We did not use not use either of the cut-off score recommendations (i.e., 3 or 6) because a
majority of the participants had a score of zero (i.e., no drug use) at 10-year follow-up.
We therefore dichotomized drug use at 10-year follow-up into Yes, indicative of any drug
use (DAST-20 score is greater than zero) or No, indicative of no drug use (DAST-20
score is zero).
Medication Adherence
Adherence to first- or second-generation antipsychotic medication was assessed at 5-year
follow-up and at 10-year follow-up using a single-item question pertaining to the past
month and year: “Based on all available information, approximately what percentage of
time has the patient been taking medication as prescribed.” This question was
formulated based on findings from a comparison study of multiple measures of adherence
to antipsychotic medication in first-episode psychosis by Cassidy and colleagues (2010).
Responses reflected the interviewer’s estimate of medication adherence based on
information from four different subjective sources including the client, the case manager,
the family, and the treating clinician. The estimate was rated on a four-point scale: 1 (025%), 2 (26-50%), 3 (51-75%), and 4 (76-100%). In the event that the sources disagreed,
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the case was discussed and a consensus was reached based upon all available
information; however, the treating clinician's estimation carried the most weight.
The reliability of using a consensus rating of medication adherence based on different
sources has been examined in a study involving a sample of 81 clients with first-episode
psychosis, treated at a specialized early intervention service in Montreal, Quebec
(Cassidy, Rabinovitch, Schmitz, Joober, & Malla, 2010). The researchers reported that
there was good agreement between measures of adherence obtained from three different
sources including pill count, clinician report, and patient report (ICC = 0.84) (Cassidy,
Rabinovitch, Schmitz, Joober, & Malla, 2010).
Due to the lack of variability in ratings, we recoded medication adherence at 10-year
from a categorical variable to a dichotomous variable. Participants were grouped into
either less than or equal to 75% medication adherence (ratings 1 or 3) or greater than 75%
medication adherence (rating 4). Medication adherence at 10-year follow-up was reported
as a dichotomous variable in our descriptive analysis, but we were unable to use this
variable in our multivariable analyses due to a lack of variability in its distribution.

3.5! Missing Data
3.5.1!

Missing Data Approaches

We examined the amount of missing data using the following approaches:
1) Determining the total number of observations (i.e., participants) with missing data (i.e.,
missing data for one or more variables); 2) Determining the total number of variables
with an observation (i.e., participant) missing data; 3) Calculating the amount of missing
data for the exposure, outcomes, potential mediator, and potential confounding variables;
and 4) Examining the pattern and mechanism of missing data. Findings for the first three
missing data approaches are presented in Table 3.1.
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Table 3.1: Missing Data Approaches.
Missing Data Approach

n (Percent Missing)

1. Total number of observations with missing data

28 (41.2%)

2. Total number of variables with missing data (i.e., observation)

26 (60.5%)

3. Total missing data for exposure, outcomes, potential mediator, and potential confounding variables
Exposure
Duration of Untreated Psychosis (weeks)

1 (1.5%)

Outcomes
Occupational Activity (Less than 52 weeks of past year vs. 52 weeks of past year)

1 (1.5%)

Self-Perceived Recovery Score

2 (2.9%)

Mediator (Assessment Point)
Number of Hospital Admissions (Baseline to 5-year follow-up; time 1)**
Number of Hospital Admissions (5-year to 10-year follow-up; time 2)

12 (17.7%)
1 (1.5%)

Potential Confounding Variables (Assessment Point)
Gender (Baseline)

0 (0.0%)

Diagnosis of a Psychotic Disorder (Baseline)

0 (0.0%)

Positive Symptoms (10-year follow-up)

0 (0.0%)

Negative Symptoms (10-year follow-up)

0 (0.0%)

Highest Level of Education (10-year follow-up)

0 (0.0%)

Drug Use (10-year follow-up)

0 (0.0%)

Mode of Onset (Baseline)

1 (1.5%)

Perceived Social Support Score (10-year follow-up)

1 (1.5%)

Age of Onset (Baseline)

2 (2.9%)

Positive Symptoms (Baseline)

3 (4.4%)

Negative Symptoms (Baseline)

3 (4.4%)

Medication Adherence (10-year follow-up) +

4 (5.9%)

Premorbid Adjustment Score (Baseline) +

9 (13.2%)

Positive Symptoms (5-year follow-up) **

12 (17.7%)

Negative Symptoms (5-year follow-up)**

13 (19.1%)

Medication Adherence (5-year follow-up) **

14 (20.6%)

Drug Use (5-year follow-up) **

20 (29.4%)

Drug Use (Baseline) **

40 (58.8%)

Note: **Variables missing a large percentage of data and were excluded for all analyses; +Variables
not included in all analyses; n = Count; Observation = Participant; Total number of observations = 68;
Total number of variables = 43.
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For the final missing data approach, we examined the pattern and mechanism of missing
data. We had to distinguish between two patterns of missing data: 1) Monotone; and 2)
Arbitrary (Bouhlila & Sellaouti, 2013). A missing monotone pattern exists if one can
observe a clear pattern among the missing values. If no clear pattern is observed, then the
pattern of missing data is referred to as missing arbitrarily, also referred to as general or
non-monotone (Munguía & Armando, 2014).
In addition to determining the pattern of missing data, we further determined the
mechanism of missing data for which three such mechanisms exist: 1) Missing
completely at random (MCAR); 2) Missing at random (MAR); and 3) Missing not at
random (MNAR) (Little & Rubin, 2002; Rubin, 1976). MCAR describes the case where
the probability a data value missing for a particular variable is unrelated to other
measured (or observed) variables in the data set and is unrelated to the variable with
missing values itself. MAR refers to the case where the probability a data value is
missing for a variable is related to other measured (or observed) variables in the data set,
but unrelated to the variable with missing data itself. Lastly, MNAR, sometimes called
not missing at random (NMAR), describes the case where the probability a data value is
missing for a particular variable depends on the unobserved (i.e., missing) value for the
variable itself (Nakai & Ke, 2011; Vittinghoff, Glidden, Schiboski, & McCulloch, 2011).
We assumed the pattern of missing data to be missing arbitrarily and we assumed the
mechanism of missing to be MAR for all data, except for all data collected at 5-year
follow-up. For number of hospitalizations (time 1) and for data collected at 5-year
follow-up including medication adherence, drug use, positive and negative symptoms, we
assumed the pattern of missing data to be monotone and the mechanism of missing data
to be MNAR because these data were missing for those who refused to participate in the
5-year follow-up assessment. We therefore excluded all data collected at 5-year followup from all analyses.

3.5.2!

Method to Handle Missing Data

The pattern and mechanism of missing data, along with our intention to retain our entire
sample (n = 68) guided our approach to use multiple imputation (MI) to handle missing
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data in our data set (Vittinghoff, Glidden, Schiboski, & McCulloch, 2011). Compared to
single imputation methods such as mean imputation where the missing value is imputed
with the sample mean (Figure 3.2), in MI, a missing value is imputed multiple times (m
times) by a set of plausible values sampled from an imputation model (Karahalios,
Baglietto, Carline, English, & Simpson, 2012; Vittinghoff, Glidden, Schiboski, &
McCulloch, 2011; White, Royston, & Wood, 2011).
Prior to executing MI, we had to decide whether we wanted to construct our imputation
model using the multivariate normal or the chained equations approach (Bouhlila &
Sellaouti, 2013; Karahalios, Baglietto, Carline, English, & Simpson, 2012; Vittinghoff,
Glidden, Schiboski, & McCulloch, 2011), and we had to decide on the number of
imputations (m). We decided to use the chained equations approach, sometimes referred
to as imputation using chain equations (ICE) or multiple imputation by chained equations
(MICE) (Bouhlila & Sellaouti, 2013). We selected MICE because of its unique ability to
handle different types of variables such as continuous, binary, and categorical, by
modelling each variable using a model tailored to its distribution. For instance, linear
regression for a continuous variable and logistic regression for a binary variable.
(Bouhlila & Sellaouti, 2013; Vittinghoff, Glidden, Schiboski, & McCulloch, 2011). We
also selected 50 imputations (m = 50) based on the following rule of thumb, “The number
of imputations should be similar to the percentage of cases that are incomplete” (Bodner,
2008; Von Hippel, 2009). We did not impute data for our outcomes of interest, and
participants missing these data were excluded (n = 3).
The execution of MI involves three steps (Figure 3.2); 1) Impute -The missing values are
imputed m times to generate m complete data sets by sampling from a specified
imputation model; 2) Analyze- The m completed data sets are analyzed to obtain m sets
of parameter estimates and corresponding standard errors; and 3) Pool- The parameter
estimates and corresponding standard errors and confidence intervals for each of the m
complete data sets are averaged to yield one overall MI estimate (Biering, Hjollund, &
Frydenburg, 2015; Nakai & Ke, 2011; White, Royston, & Wood, 2011). To obtain valid
statistical inferences, the mechanism of missing data is assumed to be MAR (Bouhlila &
Sellaouti, 2013; Little & Rubin, 2002). In order to obtain valid statistical inferences with
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MI, we decided to exclude variables (i.e., all 5-year follow-up data) with missing data
assumed to be MNAR from the imputation model and from the regression models. We
also incorporated a seed number in the first step of MI in order to ensure replicability of
results.

Figure 3.2: Conceptual Depiction of the Single Imputation Process and the Multiple
Imputation Process (m = 4). Note: Modified from Nakagawa & Freckleton (2008).
Panel (A) Visually illustrates the process of single imputation. Panel (B) Visually
illustrates the process of multiple imputation.
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To ensure that our execution of MI worked, we conducted a few diagnostic checks to
compare means and frequencies of observed and computed data, as well as looking at the
variance information such as relative increase in variance, fraction of missing
information, degrees of freedom, relative efficiency, and between and within variance
estimates (UCLA, 2016).

3.6! Statistical Analyses
We conducted all statistical analyses using Stata, version 14 (StataCorp, 2015), and we
conducted all hypothesis tests using a Type I error rate set at α = 0.05, two-tailed.

3.6.1!

Attrition Analysis

We conducted an attrition analysis, comparing baseline sociodemographic and clinical
characteristics between those who participated in the 10-year follow-up assessment and
those who did not. For comparison of continuous baseline characteristics, we conducted a
two independent samples t-test, and for comparison of categorical baseline
characteristics, we conducted a chi-square test or Fisher’s exact test.

3.6.2!

Descriptive Statistics

For all included participants, we computed descriptive statistics for categorical variables
using counts, percentages, and frequencies. We summarized continuous variables using
means and standard deviations.

3.6.3!

Multicollinearity

For objectives 2, 3, and 4 of this thesis, we conducted multiple linear or logistic
regression analyses. Prior to conducting our planned regression analyses, we assessed for
degree of multicollinearity. Multicollinearity occurs when two or more of the
independent variables (X1, X2, X3), that are highly correlated with one another are
included in the same regression model and then analyzed together to predict the outcome
(Y) (Lauridesn & Mur, 2006; Mansfield & Helms, 1982). Multicollinearity can have
negative effects on estimation and on inference (Mansfield & Helms, 1982). We used
Variance Inflation Factors (VIF) to assess for the presence of problematic
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multicollinearity (VIF > 4). The exposure and potential confounding variables were
below the selected VIF cut-off value (VIF < 4), indicating that we did not have
problematic multicollinearity in our regression models. We should note that no standard
VIF cut-off value exists, and various cut-off values raging from four to ten have been
suggested and/or used in prior studies (e.g., Craney & Surles, 2002; O’Brien, 2007; Pan
& Jackson, 2008).

3.6.4!

Analysis: Objective 1

For objective 1, we conducted a point biserial correlation to examine the correlation at
10-year follow-up between our two recovery outcomes, occupational activity (less than
52 weeks of the past year vs. 52 weeks of the past year), an objective measure of
recovery, and self-perceived recovery score, a subjective measure of recovery. We
hypothesized that there would be a statistically significant positive association between
occupational activity and self-perceived recovery score at 10-year follow-up.

3.6.5!

Analysis: Objective 2

For objective 2, we conducted a simple logistic regression analysis with the duration of
untreated psychosis as the exposure variable and occupational activity as the outcome
variable. Additionally, we conducted a series of simple logistic regression analyses with
each potentially confounding variable of interest as the exposure variable and
occupational activity as the outcome variable. We then constructed two multiple logistic
regression models that included the duration of untreated psychosis as the exposure
variable, occupational activity as the outcome variable, and blocks of potentially
confounding variables identified from our conceptual framework. All baseline
confounding variables were entered as a block (Baseline-adjusted model), and all 10-year
confounding variables were entered as a block in a separate model (10-year adjusted
model). Both models additionally adjusted for gender and age of onset. We hypothesized
that a longer duration of untreated psychosis would decrease the odds of engagement in
occupational activity, adjusting for gender, age of onset, and other confounding variables.
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3.6.6!

Analysis: Objective 3

For objective 3, we conducted a simple linear regression analysis with the duration of
untreated psychosis as the exposure variable and self-perceived recovery score as the
outcome variable. Additionally, we conducted a series of simple linear regression
analyses with each potentially confounding variable of interest as the exposure variable
and self-perceived recovery score as the outcome. We then constructed two multiple
linear regression models that included the duration of untreated psychosis as the exposure
variable, self-perceived recovery score as the outcome variable, and adjusted for blocks
of confounding variables identified from our conceptual framework. All baseline
confounding variables were entered as a block (Baseline-adjusted model) and then
gender, age of onset, and all 10-year confounding variables were entered as a block (10year adjusted model) in a separate model. We hypothesized that there will be a
statistically significant positive association between the duration of untreated psychosis
and self-perceived recovery score, adjusting for gender, age of onset, and other
confounding variables.

3.6.7!

Analysis: Objective 4

For objective 4, we used the causal steps method of mediation proposed by Baron and
Kenny (1986), in conjunction with the bootstrapping method of mediation, to determine
whether relapse is a potential mediator in the causal pathway between the duration of
untreated psychosis and self-perceived recovery score. We performed a series of four
regression analyses according to the method outlined by Baron and Kenny (1986):
(1)!Regressing self-perceived recovery score (outcome) on the duration of untreated
psychosis (exposure);
(2)!Regressing relapse (mediator) on the duration of untreated psychosis (exposure);
(3)!Regressing self-perceived recovery score (outcome) on relapse (mediator),
adjusting for the duration of untreated psychosis (exposure);
(4)!Regressing self-perceived recovery score (outcome) on both the duration of
untreated psychosis (exposure) and relapse (mediator).
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If relapse is in fact a mediator, the following conditions must be met: (A) The duration of
untreated psychosis (exposure) is significantly correlated with relapse (mediator); (B)
Relapse (mediator) is significantly correlated with self-perceived recovery score
(outcome); and (C) When the effect of relapse (mediator) is controlled, the significant
relationship between the duration of untreated psychosis (exposure) and self-perceived
recovery score (outcome) either becomes not statistically significant (i.e., full mediation)
or greatly attenuated (i.e., partial mediation) (Baron & Kenny, 1986). We adjusted for all
potentillay confounding variables in the mediation analysis.
We decided to conduct the causal steps method of mediation regardless of the result (i.e.,
statistically significant or not statistically significant) of step 1. Researchers (e.g. Shrout
and Bolger, 2002; Zhao, Lynch, & Chen, 2010), including Kenny himself (Kenney et al.,
1998) have stated that the first step can often be overlooked in many cases because the
absence of a relationship between the exposure (X) and the outcome (Y) in the context of
mediation can occur for several reasons (as cited in Pardo & Roman, 2013). For instance,
Shrout and Bolger (2002) argue that the further apart the exposure (X) and outcome (Y)
are from one another in the causal chain, the less likely the relationship (if any) between
the two variables will be statistically significant. This may perhaps be attributed to
unidentified suppressing or moderating variables, which are altering the relationship
between the exposure (X) and the outcome (Y) (Mackinnon, Krull, & Lockwood, 2000;
Shrout and Bolger, 2002).
To assess for indirect effects, we used the bootstrap method of mediation developed by
Preacher and Hayes (2008). As compared to traditional tests such as the Sobel test, the
bootstrap method does not require the assumption of a normal distribution of the indirect
effects to be met (Preacher & Hayes, 2008). Furthermore, it has been suggested to use
bootstrap methods to assess mediation in experimental and non-experimental studies that
have small to moderate sample sizes (Shrout & Bolger, 2002). In order to calculate the
bias-corrected 95% confidence interval (BC 95% CI), we used 5000 bootstrap resamples.
The indirect effect is deemed statistically significant, when the BC 95% CI does not
contain the value of zero.
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3.6.8!

Sensitivity Analyses

We preformed sensitivity analyses to assess the robustness of findings by conducting the
analyses for objectives two, three, and four again, using complete data (n = 40). We also
repeated these sensitivity analyses using the imputed data (n = 65), with the duration of
untreated illness substituted for the duration of untreated psychosis, as the exposure
variable in the regression models. Prior to conducting the latter sensitivity analyses, we
assessed the distribution of the duration of untreated illness, which was positively
skewed. For comparability of results, we normalized the duration of untreated illness
distribution by using a square root transformation, an approach used by other researchers
in the field (e.g., Norman et al., 2012). We used the transformed duration of untreated
illness variable as a continuous variable in all sensitivity analyses.
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Chapter 4!!

4!

Results

In this chapter, the sample is described in Section 4.1, including presentation of
descriptive statistics for sociodemographic and clinical characteristics of the sample. In
Section 4.2, findings from the attrition analysis are presented, comparing baseline
sociodemographic and clinical characteristics between those who did and did not
participate at 10-year follow-up. In Section 4.3, results of a bivariate analysis conducted
for objective 1 are reported. Thereafter in Section 4.4, the results of a series of simple and
multiple logistic regression analyses conducted for objective 2 are presented.
Subsequently, in Section 4.5, the results of a series of simple and multiple linear
regression analyses conducted for objective 3 are presented. Next in Section 4.6, findings
from the mediation analysis are described. Lastly, findings from our sensitivity analyses
are reported in Section 4.7.

4.1! Sample
Of the cohort of 132 clients admitted to PEPP (March 1997 to February 2002) for
treatment of a first episode of psychosis, 56 clients were followed up at 5-years and 68
clients were followed up at 10-years. An overview of participation at each of the three
assessment points is presented in Figure 4.1. Although 68 clients participated at 10-year
follow-up, we excluded three participants from analyses because they were missing data
for one of the two outcome variables, specifically self-perceived recovery score (n = 2) or
occupational activity (n = 1). Thus, our final sample included 65 clients (Figure 4.1).
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Cohort of People with First-Episode Psychosis Admitted to
PEPP (Baseline)
(n = 132)

Participated in 5-Year Follow-Up
(n = 56)

Did Not Participate in 5-Year Follow-Up
(n = 76)
Refused to Participate (n = 32)
Lost to Follow-Up (n = 32)

Participated in 10-Year Follow-Up
(n = 56)

Participated in 10-Year Follow-Up
(n = 12)

Total Number of Clients that Participated in 10-Year
Follow-Up Study
(n = 68)
Missing Outcome (n = 3)
- Self-Perceived Recovery Score: n = 2
- Occupational Activity: n = 1

Total Number of Clients Included in Analyses
(n = 65)

Figure 4.1: Flow-Chart Outlining Participation and Non-Participation in a
Prospective Cohort Study at Baseline, 5-Year Follow-Up, and 10-Year Follow-Up.
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4.1.1!

Descriptive Statistics of the Sample

The sociodemographic and clinical characteristics of the sample at baseline and 10-year
follow-up are summarized in Tables 4.1 and 4.2, respectively. The sample was comprised
of a higher proportion of males (75%) than females (25%). Mean age was 38.8 years (SD
= 8.6) with a range between 26 to 60 years, and the mean duration of untreated psychosis
was 67.4 weeks (SD = 139.3) with a range between 0.1 to 917.7 weeks. A majority of the
participants were Caucasian (88%), were single (63%), diagnosed with a schizophreniaspectrum disorder (85%), lived with others (63%), generated an annual income of less
than $10, 000 to $29,999 (80%), and reported no drug use (74%). Over half of the
participants completed at least some post-secondary education (52%). Additionally, over
half of the participants were employed (54%), while the remainder (46%) were
unemployed. None of the participants identified student, homemaker, or retired as their
employment status.

4.2! Attrition Analysis
An overall follow-up rate of 52% (68/132) was attained at the 10-year assessment point.
Comparison between participants (n = 56) and non-participants (n = 76) revealed no
statically significant differences on any of the baseline sociodemographic or clinical
characteristics (Table 4.3).
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Table 4.1: Sociodemographic and Clinical Characteristics of the Sample (n = 65) at
Baseline.
Characteristic
Baseline
Gender*
Male
Female
Mode of Onset*
Acute
Insidious
Diagnosis of a Psychotic Disorder*
Schizophrenia-Spectrum
Schizophrenia- Disorganized
Schizophrenia-Paranoid
Schizophreniform
Schizoaffective
Schizophrenia-Undifferentiated
Other Psychotic Disorder
Substance-Induced Psychosis
Bipolar I with Psychotic Features
Major Depression with Psychotic Features
Brief Psychotic Disorder
Psychosis Not Otherwise Specified
Characteristic
Age of Onset (years)*
Premorbid Adjustment (score)
Positive Symptoms (total global items score)*
Negative Symptoms (total global items score)*
DUP (weeks)*
DUI (weeks)*

n (%)

49 (75.4)
16 (24.6)
13 (20.3)
51 (79.7)

Mean (SD)
23.9 (8.0)
0.3 (0.2)
10.4 (3.3)
11.6 (5.2)
67.4 (139.3)
284.9 (298.6)

55 (84.6)
3 (4.6)
17 (26.2)
1 (1.5)
10 (15.4)
24 (36.9)
10 (15.3)
1 (1.5)
3 (4.6)
1 (1.5)
2 (3.1)
3 (4.6)
Median
21.8
0.3
10
12
23.6
198.4

Range
10.0 to 46.5
0.0 to 0.8
2 to 17
2 to 23
0.1 to 017.7
0.0 to 1206.7

Note: * Included in simple and multivariable regression analyses; n = count (frequency);
SD = Standard Deviation; DUP = Duration of Untreated Psychosis (weeks);
DUI = Duration of Untreated Illness (weeks); % = Percentage.
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Table 4.2: Sociodemographic and Clinical Characteristics of the Sample (n = 65) at
10-Year Follow-Up.
Characteristic
10-year Follow-up
Ethnicity
Caucasian
Black/African American
Native American/American Indian
Asian/Pacific Islander
Other
Marital Status
Single (Never Married)
Married/Common Law
Divorced/Separated
Widowed
Highest Level of Education Attained*
Less than or completed high school
Some post-secondary
Living Arrangement
Lives Alone
Lives with Other(s)
Employment Status
Employed
Unemployed
Annual Income
Less than $10, 000 to $29, 999
$30, 000 to $49, 999
Drug Use*
No
Yes
Medication Adherence
Less than or equal to 75%
Greater than 75%
Characteristic
Age (years)
Total Years of Formal Education
Perceived Social Support (score)*
Positive Symptoms (total global items score)*
Negative Symptoms (total global items score)*

n (%)

57 (87.7)
2 (3.1)
3 (4.6)
2 (3.1)
1 (1.5)
41 (63.1)
18 (27.7)
5 (7.7)
1 (1.5)
31 (47.7)
34 (52.3)
24 (37.0)
41 (63.0)
35 (53.8)
30 (46.2)
52 (80.0)
13 (20.0)
48 (73.9)
17 (26.1)

Mean (SD)
38.8 (8.6)
13.1 (2.1)
31.5 (6.5)
3.8 (3.4)
6.0 (5.5)

5 (8.20)
56 (91.80)
Median
36
13
33
3
4

Range
26 to 60
8 to 17
14 to 40
0 to 14
0 to 18

Note: * Included in simple and multivariable regression analyses; n = count (frequency);
SD = Standard Deviation; % = Percentage.
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Table 4.3: Comparison of Baseline Sociodemographic and Clinical Characteristics
between Participants (n = 56) and Non-Participants (n = 76) at 10-Year Follow-Up.
Characteristic
Sociodemographic
Gender n (%)
Male
Female
Highest Level of Education n (%)
Special education
Less than high school diploma
High school diploma
Some post-secondary
Marital Status n (%)
Single
Married/Common Law/Stable Relationship
Separated
Clinical
Age of Onset (years) Mean (SD)
Premorbid Adjustment (score) Mean (SD)
DUP (weeks) Mean (SD)
DUI (weeks) Mean (SD)
Positive Symptoms (total global items) Mean (SD)
Negative Symptoms (total global items) Mean (SD)
Diagnosis of a Psychotic Disorder n (%)
Schizophrenia-Spectrum
Schizophrenia-Disorganized
Schizophrenia-Paranoid
Schizophreniform
Schizoaffective
Schizophrenia-Undifferentiated
Other Psychotic Disorder
Substance-Induced Psychosis
Bipolar I with Psychotic Features
Major Depression with Psychotic Features
Brief Psychotic Disorder
Psychosis Not Otherwise Specified

Participants
(n = 56)

Non-Participants
(n = 76)

P-value

0.91
43 (77)
13 (23)

59 (78)
17 (22)

1 (1.8)
24 (42.9)
11(19.6)
20 (35.7)

5 (6.6)
34 (44.7)
20 (26.3)
17 (22.4)

46 (82.1)
7 (12.5)
3 (5.4)

63 (82.9)
11 (14.5)
2 (2.6)

24.2(8.2)
0.3(0.2)
53.5 (92.0)
271.6 (289.1)
10.5 (3.2)
11.8 (5.1)

23.5 (8.2)
0.3 (0.1)
88.6 (125.3)
287.1 (251.5)
10.1 (3.5)
11.9 (4.9)

4 (7.1)
16 (28.6)
2 (3.6)
9 (16.1)
17 (30.3)

5 (6.6)
26 (34.2)
2 (2.6)
12 (15.8)
15 (19.7)

1 (1.8)
2 (3.6)
1 (1.8)
1 (1.8)
3 (5.3)

7 (9.2)
5 (6.6)
0 (0.0)
0 (0.0)
3 (3.9)

0.36

0.80

Note: DUP = Duration of Untreated Psychosis (weeks); DUI = Duration of Untreated
Illness (weeks); n = count; SD = Standard Deviation; % = Percentage.

0.64
0.45
0.45
0.06
0.52
0.91
0.54
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4.3! Objective 1
At 10-year follow-up, participants were engaged in occupational activity for either less
than 52 weeks of the past year (n = 33) or for 52 weeks of the past year (n = 32).
At 10-year follow-up, the mean total self-perceived recovery score obtained by
participants on the MARS was 106.9 (SD = 13.2). The total MARS scores ranged from
70 to 125. The distribution of the total MARS scores within the sample (n = 65) is
presented in Figure 4.2.

Figure 4.2: Total MARS Scores for Sample (n = 65).
The point biserial (pbi) correlation coefficient revealed a positive association between
self-perceived recovery score, a subjective measure of recovery, and occupational activity
(less than 52 weeks of the year vs. 52 weeks of the year), an objective measure of
recovery, at 10-year follow-up; however, this association was not statistically significant
(rpbi = 0.14, P = 0.28).
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4.4! Objective 2
4.4.1!

Variables Associated with Objective Recovery

Table 4.4 contains the results of the unadjusted, baseline adjusted, and 10-year adjusted
regressions models, with the duration of untreated psychosis as the exposure variable, and
occupational activity as the outcome variable.
Duration of Untreated Psychosis
Across all regression models, results revealed no statistically significant association
between the duration of untreated psychosis and occupational activity at 10-year followup (Table 4.4). In the unadjusted and the baseline adjusted regression models, the
magnitude of the odds ratio is less than one, but in the 10-year adjusted regression model,
the magnitude of the odds ratio is greater than one.
Highest Level of Education
Findings from the unadjusted regression model revealed a statistically significant
association between some post-secondary education and occupational activity at 10-year
follow-up (OR = 3.32, 95% CI: 1.21 to 9.21). However, this result was no longer
statistically significant in the 10-year adjusted regression model.
Negative Symptoms Score
In both the unadjusted and 10-year adjusted regression models, results revealed a
statistically significant association between negative symptoms score at 10-year followup and occupational activity at 10-year follow-up (OR = 0.73, 95% CI: 0.63 to 0.85; OR
= 0.69, 95% CI: 0.57 to 0.84). In both regression models, the magnitude of the odds ratio
was less than 1, suggesting that the odds of engagement in occupational activity in the
past year decreases, as number of negative symptoms increases. Findings further
indicated that the magnitude of the odds ratio slightly attenuated with the addition of
confounding variables (Table 4.4).
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Table 4.4: Unadjusted and Adjusted Logistic Regression Models with DUP as the Exposure Variable and Occupational
Activity (Less than 52 weeks in past year vs. 52 weeks of the past year) as the Outcome Variable (n = 65).
Potential Confounding
Variables
DUP* (weeks)
Baseline
Gender
Age of Onset (years)
Mode of
Onset
Diagnosis of a Psychotic Disorder
Positive Symptoms (score)
Negative Symptoms (score)
10-year Follow-up
Highest Level of Education

Perceived Social Support (score)
Drug Use
Positive Symptoms (score)
Negative Symptoms (score)

Value

Unadjusted
OR (95% CI)

Baseline Adjusted
OR (95% CI)

10-Year Adjusted
OR (95% CI)

N/A

0.91 (0.77 to 1.20)

0.91 (0.67 to 1.26)

1.26 (0.81 to 1.95)

Male
Female
N/A
Acute
Insidious
Other Psychotic Disorder
Schizophrenia-Spectrum
N/A

Ref.
1.34 (0.43 to 4.18)
1.03 (0.97 to 1.09)
Ref.
0.33 (0.09 to 1.21)
Ref.
0.38 (0.09 to 1.65)
0.92 (0.79 to 1.08)

Ref.
1.05 (0.30 to 3.74)
1.03 (0.95 to 1.12)
Ref.
0.31 (0.08 to 1.26)
Ref.
0.48 (0.10 to 2.29)
0.93 (0.79 to 1.12)

Ref.
1.90 (0.31 to 11.59)
0.97 (0.87 to 1.07)
-

N/A

0.99 (0.90 to 1.08)

1.04 (0.92 to 1.17)

-

Less than or Completed
High School
Some Post-Secondary
N/A
No
Yes
N/A
N/A

Ref.

-

Ref.

3.32 (1.21 to 9.21)**
1.13 (1.02 to 1.23)**
Ref.
0.82 (0.27 to 2.48)
0.86 (0.73 to 1.01)
0.73 (0.63 to 0.85)**

-

2.89 (0.67 to 12.30)
1.13 (1.00 to 1.28)
Ref.
0.29 (0.05 to 1.72)
0.86 (0.69 to 1.07)
0.69 (0.57 to 0.84)**

Note: * Exposure; ** Indicates statistically significant findings; OR = Odds Ratio; CI = Confidence Interval; DUP = Duration of Untreated Psychosis
(weeks); Ref. = Reference Group; N/A = Not Applicable; A statistically significant association between occupational activity and DUP or confounding
variables exists when the 95% CI does not contain the value of one.
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Perceived Social Support Score
Findings from the unadjusted regression model (OR = 1.13, 95% CI: 1.02 to 1.23)
indicated a statistically significant association between perceived social support score at
10-year follow-up and occupational activity at 10-year follow-up, but the association was
no longer statistically significant association in the 10-year adjusted regression model.

4.5! Objective 3
4.5.1!

Variables Associated with Subjective Recovery

Table 4.5 summarizes the results of the unadjusted, baseline adjusted, and 10-year
adjusted regression models, with the duration of untreated psychosis as the exposure
variable, and self-perceived recovery score as the outcome variable.
Duration of Untreated Psychosis
Results revealed no statistically significant association between the duration of untreated
psychosis and self-perceived recovery score at 10-year follow-up across all regression
models (Table 4.5). In general, findings indicated that the magnitude of the effect is
attenuated with the addition of confounding variables.
Negative Symptom Score
Findings indicated a statistically significant association between negative symptom score
at 10-year follow-up and self-perceived recovery score at 10-year follow-up in the
unadjusted regression model (β = -0.71, 95% CI: -1.29 to -0.13), but not in the 10-year
adjusted regression model (Table 4.5).
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Table 4.5: Unadjusted and Adjusted Linear Regression Models with DUP as the Exposure Variable and Self-Perceived
Recovery Score as the Outcome Variable (n = 65).
Potential Confounding
Variables
DUP* (weeks)
Baseline
Gender
Age of Onset (years)
Mode of
Onset
Diagnosis of a Psychotic Disorder

Positive Symptoms (score)
Negative Symptoms (score)
10-year Follow-up
Highest Level of Education

Perceived Social Support (score)
Drug Use
Positive Symptoms (score)
Negative Symptoms (score)

Value

Unadjusted
β (95% CI)

Baseline Adjusted
β (95% CI)

10-Year Adjusted
β (95% CI)

N/A

-1.24 (-3.04 to 0.56)

-1.57 (-3.50 to 0.36)

-0.73 (-2.42 to 0.97)

Male
Female
N/A
Acute
Insidious
Other Psychotic
Disorder
Schizophrenia-Spectrum
N/A

Ref.
-2.49 (-10.14 to 5.16)
0.00 (-0.42 to 0.43)
Ref.
-5.75 (-13.69 to 2.20)
Ref.

Ref.
-3.61 (-11.83 to 4.60)
0.08 (-0.41 to 0.57)
Ref.
-7.31 (-15.65 to 1.03)
Ref.

Ref.
-5.07 (-12.45 to 2.31)
0.10 (-0.32 to 0.53)
-

-0.78 (-9.95 to 8.38)
0.39 (-0.63 to 1.41)

1.25 (-8.56 to 11.05)
0.44 (-0.67 to 1.55)

-

N/A

0.09 (-0.55 to 0.73)

0.11 (-0.65 to 0.87)

-

Less than or Completed
High School
Some Post-Secondary
N/A
No
Yes
N/A
N/A

Ref.

-

Ref.

5.00 (-1.50 to 11.50)
1.01 (0.55 to 1.27)**
Ref.
3.43 (-4.05 to 10.90)
-0.40 (-1.37 to 0.57)
-0.71 (-1.29 to -0.13)**

-

2.99 (-3.21 to 9.19)
0.94 (0.45 to 1.42)**
Ref.
2.51 (-4.32 to 9.35)
0.14 (-0.79 to 1.07)
-0.36 (-0.95 to 0.24)

Note: * Exposure; ** Indicates statistically significant findings; β = Beta Coefficient; CI = Confidence Interval; DUP = Duration of Untreated Psychosis
(weeks); Ref. = Reference Group; N/A = Not Applicable; A statistically significant association between self-perceived recovery score and DUP or
confounding variables exists when the 95% CI does not contain the value of zero.
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Perceived Social Support Score
In both the unadjusted and 10-year adjusted regression models, results revealed a statistically
significant association between perceived social support score at 10-year follow-up and selfperceived recovery score at 10-year follow-up (β = 1.01, 95% CI: 0.55 to 1.27; β = 0.94, 95%
CI: 0.45 to 1.42). In both regression models, the direction of the effect was positive, which
suggests that as social support increases, self-perceived recovery increases. Results further
revealed that the magnitude of the effect slightly attenuated with the addition of confounding
variables (Table 4.5).

4.6! Objective 4
Figure 4.3 visually illustrates our mediation analysis.
A. Unmediated Model
DUP
(X)

c

Self-Perceived
Recovery Score (Y)

B. Mediated Model

a

DUP
(X)

Relapse
(M)

c’

b

Self-Perceived
Recovery Score (Y)

Figure 4.3: Hypothesized Mediation Model with Relapse as the Mediator in the
Relationship between DUP and Self-Perceived Recovery Score. Note: DUP = Duration of
Untreated Psychosis; X = Exposure; Y = Outcome; M = Mediator. A. Unmediated model: Path c
illustrates the total effect of DUP on self-perceived recovery score (no mediator). B. Mediated
model: Path a illustrates the direct effect of DUP on relapse. Path b illustrates the direct effect of
relapse on self-perceived recovery score after controlling for DUP. Path c’ depicts the direct
effect of DUP on self-perceived recovery score after controlling for relapse.
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The results of each of the four regression analyses corresponding to the four steps of the
causal steps method of mediation (Baron & Kenny, 1986) are presented in Table 4.6.
Regression analyses for all four steps were not statistically significant, suggesting no
evidence of a mediating effect of relapse on the association between the duration of
untreated psychosis and self-perceived recovery score.
Table 4.6: Testing for Mediation Using the Causal Steps Methods of Mediation
(n = 65).
Step (Regression Analysis)
1.! Conduct a regression analysis with X and Y.

Variable
(Exposure)
DUP

β [95% CI]
(Exposure)
-1.12 (-2.88 to 0.64)

Pathway
(Figure 4.3)
c

2.! Conduct a regression analysis with X and M.

DUP

-0.16 (-0.39 to 0.07)

a

3.! Conduct a regression analysis with M and Y, adjusting for X.

Relapse

0.04 (-2.26 to 2.34)

b

4.! Conduct a regression analysis with X and Y, adjusting for M.

DUP

-1.17 (-3.00 to 0.65)

c’

Note: DUP = Duration of Untreated Psychosis; X = Exposure = DUP (weeks); Y =
Outcome = Self-Perceived Recovery Score; M = Mediator = Relapse; β = Beta
Coefficient. The direct effects are statistically significant at the 95% confidence interval
(CI), when the 95% CI does not include 0.
Findings from the bootstrap method of mediation (Preacher & Hayes, 2008) indicated
that the indirect effect of the duration of untreated psychosis on self-perceived recovery
score via relapse is not statistically significant (β = -0.00, BC 95% CI: -0.34 to 0.23).

4.7! Sensitivity Analyses
4.7.1!
4.7.1.1!

Sensitivity Analyses for Complete Data
Objective 2

In contrast to the main analyses, results from the sensitivity analyses with participants
who had complete data (n = 40) revealed that the magnitude of the odds ratio for the
duration of untreated psychosis across all three regression models were slightly larger,
and the corresponding 95 % CI’s were slightly wider, but remained non-significant.
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All other findings were consistent with the findings from the main analyses.

4.7.1.2!

Objective 3

In contrast to the main analyses, results from the sensitivity analyses with participants
who had complete data (n = 40) revealed that in the unadjusted (β = -1.29, 95% CI: -3.86
to 1.28) and baseline adjusted (β = 2.12, 95% CI: -5.04 to 0.80) regression models, the
magnitude of the effect of the duration of untreated psychosis was larger and the
corresponding 95% CI’s were wider but remained non-significant. In the 10-year adjusted
regression model (β = -0.38, 95% CI: -2.68 to 1.92), the magnitude of the effect of the
duration of untreated psychosis was smaller and the corresponding 95% CI was narrower.
In contrast to the findings of the main analyses, findings from the 10-year adjusted
regression model revealed a statistically significant association between negative
symptoms score at 10-year follow-up and self-perceived recovery score at 10-year
follow-up (β = -1.04, 95% CI: -1.75 to -0.32). In the unadjusted (β = -1.28, 95% CI: -1.94
to -0.63) and 10-year adjusted (β = -1.04, 95% CI: -1.75 to -0.32) regression models, the
magnitude of the effect was larger and the corresponding 95% CI’s were wider than those
in the main analyses.
All other findings were consistent with the findings of the main analyses.

4.7.1.3!

Objective 4

Findings from the sensitivity analyses using participants with complete data (n = 40) to
assess the hypothesized mediation model are consistent with the main findings using
imputed data.

4.7.2!
4.7.2.1!

Sensitivity Analyses for Measure of Untreated Illness
Objective 2

In contrast to the findings from the main analyses with the duration of untreated
psychosis as the exposure variable, findings from the sensitivity analyses with the
duration of untreated illness as the exposure variable revealed a statistically significant
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association between the duration of untreated illness and occupational activity at 10-year
follow-up in the unadjusted (OR = 0.93, 95% CI: 0.88 to 0.99) and baseline adjusted
(OR = 0.92, 95% CI: 0.86 to 0.99) regression models. In the 10-year adjusted regression
model, the magnitude of the odds ratio for the duration of untreated psychosis was less
than one, which suggests that the odds of engagement in occupational activity in the
previous year decreases as the duration of untreated illness increases.
All other findings were consistent with the findings of the main analyses.

4.7.2.2!

Objective 3

In contrast to the findings from the main analyses with the duration of untreated
psychosis as the exposure variable, findings from the sensitivity analyses with the
duration of untreated illness as the exposure variable revealed a statistically significant
association between the duration of untreated illness and self-perceived recovery score at
10-year follow-up in the unadjusted (β = -0.66, 95% CI: -1.00 to -0.33), baseline adjusted
(β = -0.65, 95% CI: -1.03 to -0.28), and 10-year adjusted (β = -0.52, 95% CI: -0.87 to 0.16) regression models. These findings suggest that as the duration of untreated illness
increase, self-perceived recovery decreases. Across all models, the magnitude of the
effect was smaller and the corresponding 95% CI’s were narrower.

4.7.2.3!

Objective 4

In contrast to the main analyses, findings from the sensitivity analyses that included the
duration of untreated illness as the exposure variable in the hypothesized mediation
model revealed that steps 1 and 4 of the causal steps method of mediation were
statistically significant.
All other findings were consistent with the main analyses.
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Chapter 5!!

5!

Discussion & Conclusion

In this final chapter, key findings from the analyses conducted for each of the four
objectives of this thesis are discussed in the context of existing literature. Section 5.1
begins with a discussion of the findings from the bivariate analysis examining the
association between the two recovery outcomes at 10-year follow-up (Objective 1). Next,
the findings from multiple logistic and linear regression analyses investigating whether
the duration of untreated psychosis is associated with occupational activity (objective
recovery) and/or self-perceived recovery score (subjective recovery) at 10-year followup, adjusting for confounding variables (Objectives 2 & 3) are discussed. Subsequently,
findings from the mediation analysis investigating whether relapse mediates the
relationship between the duration of untreated psychosis and self-perceived recovery
score at 10-year follow-up (Objective 4) are discussed. Next in Section 5.2, evidence
from previous studies reporting a differential relationship of the duration of untreated
psychosis and the duration of untreated illness to particular outcome measures is
provided. Thereafter in Section 5.3, the strengths of this thesis are discussed, followed by
a discussion of the limitations in Section 5.4. Finally, clinical implications are discussed
in Section 5.5, and an overall conclusion is provided in Section 5.6.

5.1! Summary of Key Findings by Study Objective
5.1.1!

Objective 1

Several empirical studies have investigated the relationship between objective and
subjective recovery from psychotic disorders (e.g., schizophrenia) or other serious mental
illness (Jørgensen et al., 2015; Kukla, Lysaker, & Roe, 2014; Lloyd, King, & Moore,
2010; Morland, 2007; Norman, Windell, & Manchanda, 2013; Resnick, Rosenheck, &
Lehman, 2004; Roe, Mashiach-Eizenberg & Lysaker, 2011). However, findings from
these studies have been equivocal, with evidence for and against the presence of an
association between these two dimensions of recovery. Given these inconsistent findings,
we sought to examine the association between our two 10-year outcomes of interest,
specifically objective and subjective recovery from a first episode of psychosis. We
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hypothesized that there would be a statistically significant positive association between
occupational activity and self-perceived recovery score at 10-year follow-up, such that
people who attained objective recovery would have higher self-perceived recovery
scores. Results revealed a positive association between occupational activity, our
objective measure of recovery, and self-perceived recovery score, our subjective measure
of recovery; however, contrary to our hypothesis, the positive association was not
statistically significant. This finding is consistent with results of previous studies (Kukla,
Lysaker, & Roe, 2014; Roe, Mashiach-Eizenberg & Lysaker, 2011), suggesting that selfassessment of recovery from first-episode psychosis and other psychotic disorders is
independent of occupational activity, symptom severity (Roe, Mashiach-Eizenberg &
Lysaker, 2011), level of functioning (Roe, Mashiach-Eizenberg & Lysaker, 2011), and
the presence of positive and negative symptoms (Kukla, Lysaker, & Roe, 2014), which
are all objective measures of recovery. In other words, one’s perception of recovery is not
determined by some persisting, overt, and measureable characteristics that have been
compromised by or associated with the diagnosis itself.
Inconclusive evidence regarding the presence or absence and direction of an association
between objective and subjective recovery may perhaps be attributed to the following
differences: 1) How objective and subjective recovery are operationalized and measured;
and 2) Number of assessment points.
1. Operationalization and Measurement of Subjective and Objective Recovery.
Variability in the operationalization and measurement of subjective and objective
recovery across studies precludes comparability because the same construct is not being
assessed. In some studies, operationalization of subjective and objective recovery may
refer to total scores (Kukla, Lysaker, & Roe, 2014; Morland, 2007; Roe, MashiachEizenberg & Lysaker, 2011), individual domains/subscales (Norman, Windell, &
Manchanda, 2013; Resnick, Rosenheck, & Lehman, 2004), or a combination of total
scores and individual domains/subscales (Jørgensen et al., 2015; Llyod, King, & Moore,
2010) of the measures used to assess subjective and objective recovery. Subjective
recovery (i.e., self-reported recovery) has been assessed with different measures - in this
thesis we used the MARS (total score), whereas others have used the Recovery
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Assessment Scale (Jørgensen et al., 2015; Kukla, Lysaker, & Roe, 2014; Lloyd, King, &
Moore, 2010; Norman, Windell, & Manchanda, 2013; Roe, Mashiach-Eizenberg &
Lysaker, 2011) or the Mental Health Recovery Scale (Morland, 2007). Furthermore,
objective recovery in this thesis was defined by occupational activity (less than 52 weeks
of past year vs. 52 weeks of past year), in other studies, objective recovery refers to the
assessment or severity of symptoms. (Kukla, Lysaker, & Roe, 2014; Morland, 2007;
Norman, Windell, & Manchanda, 2013; Resnick, Rosenheck, & Lehman, 2004; Roe,
Mashiach-Eizenberg & Lysaker, 2011). The measures used to assess objective recovery
defined by symptoms or the severity of symptoms also varies across studies. For instance,
Kukla and colleagues (2014) and Morland (2007) used the Positive and Negative
Symptoms Scale, whereas Norman and colleagues (2013) used the SAPS and SANS,
while Resnick and colleagues (2004) used the shortened version of the Symptom
Checklist, and Roe and colleagues (2011) used the Brief Psychiatric Rating Scale
Expanded. Future studies should therefore adhere to the same operationalization of
objective and subjective recovery, as well use consistent recovery measures to allow
comparison of findings across studies.
2. Number of Assessment Points. Assessment of objective and subjective recovery at a
single time-point does not capture the fluctuating nature of recovery over time. A
majority of studies, including this thesis, assessed the relationship between objective and
subjective recovery at a single time-point (Kukla, Lysaker, & Roe, 2014; Lloyd, King, &
Moore, 2010; Morland, 2007; Norman, Windell, & Manchanda, 2013; Resnick,
Rosenheck, & Lehman, 2004; Roe, Mashiach-Eizenberg & Lysaker, 2011), whereas the
study conducted by Jørgensen and colleagues (2015) assessed the relationship across
multiple time-points, which allowed them to assess change over time. In the latter study,
fluctuation in the presence or absence of a relationship between domains of self-reported
recovery (subjective recovery) and domains of symptoms (objective recovery) was found
across the four time points. Future studies should therefore assess recovery at multiple
time-points to capture its changing state.
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5.1.2!

Objective 2

Austin and colleagues (2013) conducted the only study to date that investigated whether
the duration of untreated psychosis is associated with objective recovery among people
with first-episode psychosis over a long follow-up period (>10-years). To add to this
essentially non-existent body of literature, we sought to investigate whether duration of
untreated psychosis is associated with occupational activity (objective recovery), 10years after a first episode of psychosis. We hypothesized that a longer duration of
untreated psychosis would decrease the odds of engagement in occupational activity,
adjusting for gender, age of onset, and other confounding variables. Contrary to our
hypothesis, results revealed a statistically non-significant association between duration of
untreated psychosis and occupational activity (objective recovery) with or without
controlling for confounding variables, suggesting that duration of untreated psychosis is
not associated with objective recovery at 10-year follow-up among people with firstepisode psychosis. Our finding is consistent with the findings reported by Austin and
colleagues (2013); however, objective recovery was operationalized differently in each
study. In this thesis, we operationalized objective recovery (i.e., occupational activity) as
engagement in work and/or school on a full-time or part-time basis for less than 52 weeks
of the past year or for 52 weeks of the past year. In the study conducted by Austin and
colleagues (2013) with 304 people with first-episode psychosis, objective recovery was
differentiated into full and functional recovery. Functional recovery was defined as
currently engaged in work/study, a Global Assessment of Functioning-Functioning Scale
score over 60, and no psychiatric hospitalizations or living in supported housing for the
past two years (Albert et al., 2011). Full recovery was defined as stable remission of both
negative and positive symptoms and functional recovery (Liberman & Kopelowicz,
2005).
Comparison of our finding to other studies that used occupational activity as an outcome
measure suggest that perhaps there is a relationship between the duration of untreated
psychosis and objective recovery for shorter follow-up periods. Major and colleagues
(2010), in a 1-year follow-up of 114 people with first-episode psychosis, found that
longer duration of untreated psychosis decreased the likelihood of gaining or returning to
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competitive employment or an educational activity that has led to a nationally recognized
vocational qualification or degree (i.e., vocational recovery). Similarly, Norman and
colleagues (2007) reported that a shorter duration of untreated psychosis was
significantly associated with more occupational activity at 3-year follow-up among 163
people with first-episode psychosis, after adjusting for other confounding variables.
However, in a 5-year prospective study with the same cohort of participants (n = 132)
used in this thesis, the association between the duration of untreated psychosis and
occupational activity was not assessed in subsequent regression analyses because the
negative bivariate association was not statistically significant (Norman et al., 2012).
Aside from differences in length of follow-up, other possible explanations for
discrepancies in findings include the criteria used to define occupational activity, and the
stratification of duration of untreated psychosis as long or short.
Interestingly, results demonstrated that after adjusting for all confounding variables, the
only statistically significant factor associated with occupational activity (objective
recovery) at 10-year follow-up was negative symptoms score, with lower negative
symptom scores at 10-year follow-up associated with increased likelihood of engagement
in occupational activity (objective recovery) for 52 weeks of the past year at 10-year
follow-up. Our finding extends previous findings of a 5-year prospective study that
revealed a statistically significant, negative association between weeks of occupational
activity and two dimensions of negative symptoms (i.e., reduced motivation and
expressiveness) among the same cohort of participants (n = 132) used in this thesis.
(Norman, Manchanda, Harricharan, & Northcott, 2015). Taken together, these findings
suggest that the less negative symptoms a person with first-episode psychosis
experiences, the more engaged (number of weeks) he or she will be in work and/or school
on a full-time or part-time basis.

5.1.3!

Objective 3

To our knowledge, no study to date has examined the association between the duration of
untreated psychosis and subjective recovery. We hypothesized that there will be a
statistically significant negative association between the duration of untreated psychosis
and self-perceived recovery score at 10-year follow-up, such that longer duration of
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untreated psychosis would be associated with lower self-perceived recovery scores, after
adjusting for gender, age of onset, and other confounding variables. Results revealed a
negative association between duration of untreated psychosis and self-perceived recovery
score (subjective recovery) at 10-year follow-up, controlling for confounding variables.
However, we acknowledge that we conducted a secondary analysis of data, and our study
was not designed or powered to look at the association between DUP and self-perceived
recovery score. Therefore, we cannot determine if there was a negative association or
lack of power to detect one.

5.1.4!

Objective 4

Vulnerability to relapse has been perceived, by some, to impede one’s recovery from a
first episode of psychosis (Maddigan, 2011; Windell, Norman, & Malla, 2012), and it has
also been found to be a consequence of a long duration of untreated psychosis (Saravanan
et al., 2010; Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013). We thus sought to
investigate whether relapse mediates the relationship between the duration of untreated
psychosis (exposure) and self-perceived recovery score (subjective recovery; outcome),
and found no evidence of mediation. Specifically, we noted an absence of a statistically
significant relationship between our exposure and our outcome, which perhaps is
attributed to latency since we assessed our exposure at baseline and our outcome at 10year follow-up. We also noted there was no statistically significant relationship between
duration of untreated psychosis and relapse, which is inconsistent with previous findings
(Saravanan et al., 2010; Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013). A
possible explanation for the discrepancy is that the duration of untreated psychosis may
be more strongly associated with relapse during the first 5-years (i.e., baseline to 5-year
follow-up), for which we did not have data available on hospitalizations during this
period of time.
We additionally noted that there was no statistically significant relationship between
relapse and self-perceived recovery score at 10-year follow-up (subjective recovery). It is
possible that factors such as medication discontinuation may further mediate the
relationship between relapse and self-perceived recovery (Windell, Norman, & Malla,
2012).

97

The lack of evidence for mediation may perhaps be attributed to our use of a less
accurate, non-inclusive measure of relapse. We used hospitalization data as a proxy
measure of relapse, and the use of these data as an indicator of relapse among people with
first-episode psychosis using a specialization early intervention service has only 47%
specificity (Addington, Patten, McKenzie, & Addington, 2013).
We also did not have complete data available on hospitalizations occurring between
baseline and 5-year follow-up, and therefore did not include this information in our
analyses. We thus may have underestimated relapse because 80% of people who
experience a first episode of psychosis will experience a relapse during the 5-year period
after the first-episode (Gitlin, 2001; Robinson et al., 1999; Wiersma, Nienhuis, Slooff, &
Giel, 1998).

5.2! DUI vs. DUP: Relationship to Outcomes
The duration of untreated psychosis was not found to be statistically associated with
either of the two recovery outcomes in our main analyses, whereas, the duration of
untreated illness was found to be statically associated with both of the recovery outcomes
in our sensitivity analyses. This finding is consistent with previous studies that have
found the duration of untreated illness, rather than the duration of untreated psychosis, to
be more consistently associated with certain outcomes (Crumlish et al., 2009; Harris et
al., 2005; Keshavan et al., 2003; Norman et al., 2012). For instance, the duration of
untreated illness has been reported to be more consistently associated with negative
symptoms, levels of functioning, use of a disability pension, and social and occupational
functioning at 2-, 5-, and/or 8-year follow-up (Crumlish et al., 2009; Harris et al., 2005;
Keshavan et al., 2003; Norman et al., 2012). Thus, the duration of untreated illness has a
differential relationship with particular outcome measures, including recovery at 10-year
follow-up.

5.3! Strengths
Our study has several strengths. It uses a prospective study design, which allowed us to
not only assess multiple recovery outcomes simultaneously, but also assess the temporal
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relationship between the exposure (i.e., duration of untreated psychosis) and the
outcomes (i.e., objective and subjective recovery). Our prospective study was unique
because to our knowledge, no prospective study with a 10-year follow-up period has been
conducted in Canada, and no study to date has examined the association between the
duration of untreated psychosis and subjective recovery. In contrast to other prospective
or retrospective studies that assess one type of recovery outcome among people with
first-episode psychosis (e.g. Faber et al., 2011; Gumley et al., 2014; Major et al., 2010),
we assessed both types of recovery outcomes, that is, objective and subjective recovery,
We also used a standardized definition of recovery (i.e., SAMHSA definition), as well as
a standardized and validated measure of self-perceived recovery that is specific to people
with serious mental illness (i.e., MARS). We adhered to the recommendations made by
Compton and colleagues (2007) with respect to the measurement of the duration of
untreated psychosis, which involves the use of a standardized, structured interview
assessment (i.e., CORS), and the integration of information from multiple informants
(i.e., consensus-based estimate). We used multivariable regression analyses, which
allowed us to assess the independent effect of our exposure of interest (duration of
untreated psychosis), controlling for known confounding variables. Our choice of
variables to be included as confounding variables in our regression analyses was guided
by our conceptual framework we created based on findings from previous studies in the
literature. Lastly, we conducted two sets of sensitivity analyses to assess the robustness of
findings.

5.4! Limitations
Several methodological limitations in this study merit consideration in conjunction with
suggestions for future studies. Follow-up data was not available for 52% (68/132) of
participants, as they either refused to participate or were lost to follow-up. However, this
attrition rate of 52% is comparable to other prospective studies with long follow-up
periods (> 10-years), including those conducted by Wunderink and colleagues (2009),
and Albert and colleagues (2011), who reported attrition rates of 49% and 54%,
respectively.
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Given the 52% attrition rate, we acknowledge that the sample for this thesis was small in
size. The sample consisted of 68 participants, but we excluded three participants because
they were missing one of the two recovery outcome variables, for a final sample of 65
participants. The use of a small sample size in all analyses reduced the statistical power
of the study. Findings need to be replicated with a larger sample.
The combination of a small sample size, and the higher proportion of males than females
comprising the sample, precluded us from conducting subgroup analyses by gender.
Gender differences exist with respect to sociodemographic and clinical presentations
(ElTayebani, ElGamal, Roshdy, & Al-Khadary, 2014; Thorup et al., 2014), as well as
recovery (Thorup et al., 2014). Given that that males with first-episode psychosis have
significantly higher levels of negative symptoms at all times of follow-up (Thorup et al.,
2014), and that females are more likely to reach a state of recovery (Thorup et al., 2014),
it would be interesting to investigate whether females report more objective recovery,
based on our finding of an inverse relationship between negative symptoms at 10-year
follow-up and objective recovery at 10-year follow-up. Future research should investigate
gender differences with respect to recovery using a larger sample that is comprised of
roughly equal proportions of males and females.
We acknowledge that the sample, recruited from an early intervention service (outpatient
service) was not only predominantly male, but also predominantly Caucasian. Thus, these
sample characteristics may limit the generalizability of our results. Specifically, our
findings may not generalize to people receiving care from other health and social service
providers, females, people with affective psychotic disorders, or to different ethnic
groups who may have different definitions or concepts of subjective recovery. Thus,
replication of findings with a sample that addresses these sample characteristics is
needed.
Another limitation of this study is that we did not use all of the data that we had for the
65 participants. We had to exclude variables collected at 5-year follow-up including
positive and negative symptoms, medication adherence, drug use, and number of hospital
admissions. We also excluded drug use collected at baseline. Theses variables were
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excluded from all analyses because the mechanism of missing data was assumed to be
Missing Not At Random since they are all from the 5-year follow-up assessment. We
were thus unable to impute these variables because the mechanism of missing data
assumption required for multiple imputation (i.e., Missing At Random) was violated. The
exclusion of these variables from all analyses may have altered the associations observed.
We also removed premorbid adjustment score at baseline and medication adherence at
10-year follow-up from all analyses post-hoc because of the lack of variability in scores
and ratings, attributed in part to how these variables were measured. The exclusion of
these variables from our analyses may have altered the associations observed.
The combination of a large number of potential confounding variables and the small
sample size, precluded us from conducting fully-adjusted multivariable regression
models. We were therefore unable to assess the true association between duration of
untreated psychosis and the recovery outcomes because we did not control for all known
confounding variables. It is possible that after controlling for all known confounding
variables, a statistically significant association between the duration of untreated
psychosis and the recovery outcomes may have been observed.
We acknowledge that the duration of untreated psychosis was assessed retrospectively,
which means there is a high probability of recall bias from the participant and other
sources of information (e.g., family), especially for a participant with a longer duration of
untreated psychosis, and those who were experiencing a higher level of psychotic
symptoms at the time of assessment (Compton et al., 2007).
In contrast to other studies (e.g., Primavera et al., 2012; Tang et al., 2014), we included
the duration of untreated psychosis as a continuous variable in all analyses, therefore
assuming a linear relationship between the duration of untreated psychosis and outcome.
However, other researchers dichotomize the duration of untreated psychosis (e.g.,
Primavera et al., 2012; Tang et al., 2014), assuming that the likelihood that the duration
of untreated psychosis will have a negative impact on outcome increases when the
duration of untreated psychosis crosses a particular threshold (Singh, 2007). Various
threshold values in have been proposed and used to dichotomize the duration of untreated
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psychosis as “short” or “long” including less than or greater than 31 days, 3-, 6-, or 12months (Primavera et al., 2012). Perhaps if we had used the duration of untreated
psychosis as a dichotomous variable in all analyses, the findings may have been different.
We thus recommend future studies to follow Primavera and colleagues (2012) approach
of including the duration of untreated psychosis as a continuous and dichotomous
variable in all regression analyses to examine the impact on findings.
Another limitation was that data for our two recovery outcomes was only available for
10-year follow-up since both recovery outcomes were not assessed at baseline or at 5year follow-up. Given that recovery is a fairly changeable state (Albert et al., 2011), it is
possible that our findings may have been different if we examined the relationship with
our recovery outcomes at multiple time-points across the 10-year follow-up period.
Future studies should thus assess recovery outcomes at multiple time points over the
follow-up period in order to capture the changing state of recovery. Furthermore, we
were unable to use a validated instrument to measure occupational activity, our objective
measure of recovery, since no such measure exists.
We acknowledge that we dichotomized our continuous objective recovery outcome and
as a consequence we have lost statistical power and that results may potentially be biased
by our use of a data-derived cut-point value (Naggara et al., 2011).
Another limitation was that perceived social support was only assessed at 10-year followup. We had to assume that perceived social support remains constant throughout the 10year follow-up period, even though it likely fluctuates, particularly in relation to illness
trajectories.
We also note that we used a less accurate measure of relapse, specifically hospitalization
data (Section 3.1.4). Future research would benefit from using a more accurate measure
of relapse such as the recurrence of the positive symptoms of psychosis. It would then
possible to examine the influence of time to relapse and the number of relapses (recurrent
relapses) on the associations of interest.
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We further note that objective recovery may have been misclassified for older adults in
our sample who were nearing retirement age. However, we had very few people who
were over the age of 50 (n = 3), therefore this is unlikely to have impacted our findings.

5.5! Clinical Implications
A clinical implication from this thesis is that there is value in concurrently assessing
different dimensions of recovery to attain a more comprehensive overview of a person’s
recovery after a first episode of psychosis. Furthermore, the finding that negative
symptoms are statistically associated with objective recovery at 10-year follow-up can
directly inform clinical practice by way of targeting the reduction and/or elimination of
negative symptoms to enhance one’s functional status (Austin et al., 2013; Emsley,
Chiliza, & Schoeman, 2008). Similarly, the finding that perceived social support is a
statistically associated with subjective recovery at 10-year follow-up can also directly
inform clinical practice by way of fostering social support to enhance one’s subjective
recovery (Austin et al., 2013; Emsley, Chiliza, & Schoeman, 2008).

5.6! Conclusion
To our knowledge, this thesis was not only the first prospective study with a long followup period of 10-years to be conducted in Canada, but also the first study to examine
whether the duration of untreated psychosis is statistically associated with subjective
recovery among people with a first episode of psychosis, making it a unique contribution
to the existing literature. Our findings suggest that factors other than the duration of
untreated psychosis have an impact on objective and subjective recovery outcomes at 10year follow-up. Specifically, negative symptoms have an impact on objective recovery,
while perceived social support has an impact on subjective recovery at 10-year follow-up.
Further research examining factors associated with self-perceived recovery after a first
episode of psychosis is warranted.
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Appendices
Appendix A: Synonyms for Duration of Untreated Psychosis & Subjective
Recovery.
Duration of Untreated Psychosis
-!
-!
-!
-!

Treatment Delay
Delay in Treatment
Latency in Treatment
Duration of Initially Untreated
Psychosis

Subjective Recovery
-!
-!
-!
-!
-!
-!
-!

Subjective Perceptions of Recovery
Subjective Perceived Recovery
Self-Rated Recovery
Self-Perceived Recovery
Self-Described Recovery
Personal Recovery
Subjective Judgments of Recovery
from Psychosis
-! Perceived Recovery
-! Consumer-Defined Recovery
-! Self-Rated Perceptions of Recovery
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